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ABSTRACT
The advancement of sequencing technology has provided a renewed appreciation
for the diversity of life on earth with most environments being dominated by yet-uncultured
microorganisms. Analysis of 16S rRNA gene sequencing libraries of the original Human
Microbiome Project dataset revealed that approximately 70% of sequences belonged to
bacteria that were uncultured in the laboratory and current metagenomic analysis of the
human microbiome has proposed 77% of taxa lacked sequenced genomes. As the
human microbiome is important for healthy host physiology, these findings emphasize
just how little we currently know about the microorganisms that reside in the human body.
Understanding the microorganisms that make up the normal human microbiome is the
first logical step in determining, during dysbiosis and disease, how the community
changes as a whole so as to permit investigation into preventative and/or treatment
measures during disease. For example, many disease-associated lineages of bacteria in
periodontal disease remain uncultured in the laboratory and therefore limited insight is
available as to whether or not these organisms play a role in disease etiology or their
presence is a secondary effect of the disease state. Therefore, cultivating more
microorganisms from the human microbiome is critical as it enables hypothesis-driven
experimentation into the roles of those organisms in human health and disease. The work
presented here represents a two-fold approach for cultivation of bacteria from the human
oral microbiome by both classical means and by the development of a novel, “reversegenomics” approach. First, I identified a specific interaction between Desulfobulbus oralis
and Fusobacterium nucleatum that resulted in the isolation of the first Desulfobulbus
genus member from the human oral cavity and I characterized this bacterium both
physiologically and genomically. Next, I investigated what causes the recalcitrance of
some oral bacteria to cultivation and what contributes to their dependence on other
bacteria, such as F. nucleatum. Lastly, we leveraged existing public sequence data to
target specific TM7 bacteria from within the microbial community for both single-cell
genomic characterization and cultivation. Collectively this work demonstrates how
cultivation-dependent and cultivation-independent methodology can be combined to
investigate the “dark microbial matter” in the human oral cavity.
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CHAPTER ONE - Introduction
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Publication Note
Portions of this introduction will be submitted as part of a mini-review for the journal
Environmental Microbiology. Mircea Podar was invited for the review and all material
contained within this chapter was written by K.L.C.

The Human Microbiome and Uncultured Bacteria
Microbes have been evolving for billions of years on Earth, well before the
emergence of primates. Humans have co-evolved with our microbial counterpart – the
human microbiome (1, 2). We may begin acquiring our microbiome even before birth (35) and homeostasis with our microbiota is pertinent to our health (6). Soon after the
Human Genome Project was completed, the Human Microbiome Project (HMP) was
conceptualized. The HMP sought to identify all of the microorganisms residing in/on the
healthy human body so as to lay the groundwork for understanding, in part, their
ecological roles in human health and disease (1). Using metagenomics and 16S rRNA
gene analysis, the HMP began to elucidate the vast diversity of microorganisms in the
human microbiome and identified specific groups of microorganisms dominating different
niches (2). In doing so, a large collection of microbial reference genomes was produced
that further exemplified just how little we may know about the microorganisms that live
in/on the human body. These analyses have provided a robust baseline for what may
constitute a healthy human microbiome and has set the stage for further studies looking
at microbiome variations during different human states and diseases.
A healthy microbiome is important, in part, for to its abilities to provide inaccessible
nutrients for host consumption and to provide a line of defense against foreign invaders.
The field of clinical microbiology began with the culturing of microorganisms from the
human body. Historically, the main focus was on microorganisms that cause disease,
which led to Koch’s postulate by which a pathogen must be isolated from a sick individual
to be deemed the causative agent of a disease. This resulted in the development of media
that supported growth of such pathogens. Conversely, when microorganisms were
cultured from the environment, such media did not necessarily work due to organisms
having different metabolic requirements and growth dynamics. By implementing new
methods, such as the Winogradsky column, more diverse organisms could be cultured.
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Recently we have begun to appreciate this in regard to understanding the microorganisms
of the human microbiota, as 16S rRNA gene-based studies have correlated native
microbial species to human disease with many being currently uncultured in the
laboratory by standard culturing techniques (i.e. periodontitis (7)).
Preliminary analysis in 2012 by Fodor et al. of the HMP dataset identified about
70% of OTUs belonged to “uncultured” or “clone” designations (8). They further ranked
OTUs as “most wanted” for whole genome sequencing and/or cultivation if they had less
than 90% identity (16S rRNA gene V1-V3 and V3-V5 regions) to those existing in the
GOLD-Human or HMP databases and noted that only between 1.7% and 10% of total
HMP OTUs belonged to this “most wanted” list (8). It became evident that the human host
harbors numerous uncultured microorganisms, however few belong to those
phylogenetically novel bacterial lineages. More recent database mining at the 16S level
has suggested between 45%-97% of human microbiome taxa may, in fact, be cultured
(9). The advancement of sequencing and binning technology for metagenomics has
currently allowed us to move away from just 16S gene level analysis and take the whole
genome into consideration, which is important when considering the difficulty in assigning
species and strain level taxonomy (10). A recent metagenomics analysis of over 150,000
metagenomes from the human microbiota identified 77% of their metagenomeassembled genomes (MAGs) previously belonged to microorganisms with no available
genomes (either WGS of isolates or MAGs) (11). While great strides have been made in
understanding “who is there” in the human microbiome, the physiology of most microbes,
their interactions with each other, and their impact on human health and disease are just
beginning to be uncovered. More reference genomes, and most importantly more cultured
representatives, are required to advance from mere associations-based inferences so as
to permit hypothesis driven experimentation at the interface of human health and disease.

The Oral Microbiome and Oral Diseases
In 2010, the Human Oral Microbiome Database (HOMD) was created, relying
primarily on 16S rRNA gene sequences from clone libraries, that provides a
comprehensive database to house phylogenetic and genomic information pertaining to
the plethora of bacteria that reside in the oral cavity (12). At the time there was an
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estimated 619 bacterial taxa from 13 phyla making up the human oral microbiota, 96% of
them belonging to just 6 phyla, with approximately 34% of total taxa being uncultured (12,
13). Currently, the HOMD houses reference information for 770 microbial species and
has been expanded (eHOMD) to also include microorganisms of the human aerodigestive
tract (14). Of these approximately 770 microbial species, 62% have genomic data
available, however 30% remain as uncultivated phylotypes in the oral cavity
(www.homd.org v14.51)(14). There is still much to learn as to why these microorganisms
remain uncultured and what role those microorganisms play in human health and disease.
Periodontitis is a common disease that results from host inflammatory responses
to native oral bacteria (7, 15, 16) and has a complex etiology originating from within the
human oral microbiome as a result of synergistic and dysbiotic interactions between
members of the microbial community (17, 18). This inflammation results in swelling or
bleeding of the gums, tooth loss, and bone and tissue loss (7, 19). The exact etiology of
periodontal disease remains unclear due to the complexity of the changing oral microbial
community (20). Specifically, periodontal diseases do not arise from a single, easily
detectable pathogen but rather as a result of a native community shift favoring keystone
species (21). These species are capable of provoking a proinflammatory response that
can further alter the community and lead to dysbiosis (21).
The oral cavity provides a variety of niches, such as saliva, supragingival, and
subgingival locations, for the growth of distinct organisms with varying metabolic
requirements (i.e. aerobes vs. anaerobes) (22).

In 2012, Griffen et al. used 454

pyrosequencing to compare the subgingival microbial community between healthy and
chronic periodontal patients to understand how the microbial community may change as
a result of disease (7). They discovered that 53 microbial species were significantly more
abundant in health while 123 species were more abundant in disease (7). Of those
identified to associate with disease, over half were currently uncultured, with entire phyla
existing with no cultured representatives at the time (7). Likewise, using Illumina
sequencing of 16S rRNA gene libraries of the subgingival microbiome, eight specific
classes

of

bacteria

were

correlated

with

periodontitis

including

Chloroflexi,

Deltaproteobacteria, Spirochaetes, and Synergistetes (23), each encompassing yetcultured representatives (7). In addition to periodontal disease, another common disease
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is dental caries which results in dental demineralization. A survey of the supragingival
microbiome of twins with and without caries identified uncultured bacteria from the
candidate phyla TM7 and GN02 present in the samples with a particular uncultured TM7
bacterium correlating with taxa associated with caries-positive subjects (24).

Cultivation-independent Studies
Although 16S rRNA gene studies can give us an idea about “who is there”, nextgeneration sequencing provides a more comprehensive genomic analysis where we can
begin to make inferences about what these microorganisms may be doing based on their
genomic content. Two methods to sequence the genomes of currently uncultured
microorganisms from within complex microbial communities is by single-amplified
genomics (SAGs) and metagenomic-amplified genomics (MAGs). Each approach has
pros and cons and it ultimately depends on the research question being asked as to which
approach works best for which situation (reviewed in (25, 26)). One benefit of SAGs is
that the approach can be more targeted towards organisms of interest. Further, since
sequenced DNA is from a single cell, this method provides species/strain level resolution
(25, 26). Conversely, due to amplification bias associated with SAGs, MAGs tend to
provide a more complete genome with even sequencing coverage as well as the
opportunity to provide a larger microbiome-wide look at the genomic content of each
sample set (25).
An interesting group of microorganisms that reside in the human oral microbiota
belong to the “candidate phyla radiation” (CPR) (27), which includes TM7, GN02, and
SR1 bacteria, deep-branching uncultured lineages. Single-cell genomics provided an
initial view into some of these organisms in the oral cavity. The first genomic information
for TM7 came from single-cell genomes in 2007 in which the phrase microbial “dark
matter” was first coined (28). An early 16S rRNA gene clone study had previously
investigated TM7 diversity in the human oral cavity (29) and found that TM7 rRNA gene
abundance was higher in patients exhibiting periodontal disease, relative to total bacterial
rRNA, with a specific TM7 subgroup being detected more in diseased than in healthy sites
(29). That first glimpse at the genomic information contained within a TM7 genome
generated initial hypotheses as to the metabolic potential for TM7 bacteria in the oral
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cavity and recognition that they encoded Type IV secretion systems (28, 30, 31).
Furthermore, a single-cell genome of an oral SR1 bacterium identified that this particular
group of organisms harbored a unique genetic code by recoding the traditional UGA stop
codon as a glycine (32).
In addition to phylogenetically novel microorganisms, single-cell genomics has
helped elucidate the potential roles other uncultured disease-associated lineages of
bacteria may play in the oral cavity. As stated previously, 16S rRNA gene studies revealed
correlations between Deltaproteobacteria and Chloroflexi with periodontal disease (7,
23). Further single-cell genomic sequencing of these groups of organisms provided novel
insights into their host adaptation and a putative role in disease and also provided
hypotheses for cultivation in the laboratory (33, 34). Uncovering information about
disease-associated microorganisms via single-cell genomics has been useful in
furthering our understanding of health-associated species, as is the case with a previously
uncultured health-associated Tannerella species (35).
As periodontal disease and caries have a polymicrobial etiology, metagenomic
studies can resolve community-wide genomes to provide further insights into the whole
community’s functional potential (36). One of the first metagenomic studies to look at the
differences in community composition in oral health and disease was in 2012. This study
demonstrates that healthy individuals (those who had never suffered from dental caries)
were significantly enriched in certain functions relating to antimicrobial peptides and
quorum sensing (36). Based on that, it was hypothesized that some of the healthassociated oral bacteria, specifically some streptococci, could act as “probiotics” by
having an antagonistic effect on cariogenic bacteria (36). This led to cultivation of 249
isolates from healthy individuals, of which 16 were capable of inhibiting the growth of
cariogenic bacteria, most being closely related to Streptococcus oralis, S. mitis, and S.
sanguis (36).
Single-cell genomes and metagenomes can reveal the physiological potential of a
microorganism, but the functions encoded in genomes are not always expressed at either
the RNA or protein level. Further cultivation-independent approaches can harness
technologies such as transcriptomics and proteomics to measure the relative abundance
of mRNA transcripts or proteins which can serve as a representation of the metabolic
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activity of specific organisms or the microbial community as a whole. As noted in the
original HMP dataset, microbial community structure can change considerably in healthy
individuals but on a functional level may remain consistent (6). A more robust analysis of
the human oral microbiome using metatranscriptomics revealed that periodontal patients
displayed conserved metabolic profiles during disease (37). Specifically, gene expression
relating to lysine fermentation to butyrate and pyruvate fermentation were significantly
more expressed in all diseased sites indicating that these functions may be important for
influencing disease-associated microbial communities (37). RNAseq further provided
species-level resolution and revealed that Fusobacterium nucleatum was responsible for
lysine degradation to butyrate in those individuals, despite no significant change in F.
nucleatum rRNA abundance, indicating that a shift in gene expression by specific
organisms may contribute to the changing environment that results in oral diseases (37).
Similarly, specific metabolic changes occur within the microbial community during the
onset of gingivitis in which the community favors genes involved in pathways such as
propanoate and butanoate metabolism (38).
Although the information gained from sequencing studies can provide useful
insight into the functions of the human microbiota, it still remains a bioinformatics endpoint. Further cultivation of currently uncultured bacteria can fuel hypothesis-driven
studies about the role these microorganisms play in their environments. Isolation enables
us to advance from disease correlations to understanding etiology and specific
pathogenicity mechanisms so that effective treatment can be achieved.

Cultivation-dependent Studies
Some periodontal pathobionts have been identified but many disease-associated
lineages remain uncultured (17). With the 770 bacterial taxa identified in the human oral
cavity, 1/3rd represent yet-cultivated members (12, 13). Their recalcitrance to culturing
under standard culture methods may be due to their dependencies on co-evolving
bacterial community members, an idea supported by recent advances in culturing such
organisms. For example,

Fretibacterium fastidiosum (phylum Synergistetes) is

dependent upon Fusobacterium nucleatum for growth in pure culture (39). Another
example is cultivation of a human health-associated Tannerella species (40), first

7

characterized by single-cell genomics (35). That isolate, Tannerella BU063, requires
‘helpers’ such as Prevotella intermedia or Propionibacterium acnes to stimulate growth,
with colonies of BU063 forming satellites around other oral species (40). Likewise, the
first oral bacterium cultured from the phylum Chloroflexi, Chloroflexi taxon Anaerolineae
bacterium HOT439, requires ‘helper’ bacteria, including F. nucleatum, for growth (41) and
was isolated by adding siderophores to culture medium (41). These findings suggest a
reliance of these organisms on a community lifestyle, where species interact and may
depend upon each other, an aspect that needs to be considered when designing
cultivation experiments.
In some instances, catering media variations to specific growth requirements
enables successful cultivation of previously uncultured microorganisms (42, 43).
Traditional media (such as LB or BHI) used to culture bacteria does not support the growth
of a high diversity of oral bacteria (43). However, if steps are taken to develop a medium
that meets the nutritional requirements of more diverse oral microorganisms then perhaps
more organisms may be brought into culture. One such success is the development of
“SHI medium” that supports the growth of high percentages of uncultured oral bacteria
(43). Similarly, longer-term anaerobic cultivation aimed at identifying slow-growing and/or
satellite colonies on diverse media arrays was successful in isolating novel Bacteroidetes,
Lachnospiraceae and Clostridiales species (42).
Bacteria

from

the

candidate

TM7

phylum

(more

recently

renamed

“Saccharibacteria”(44)) have been recalcitrant to cultivation for many years. The first
representative to be cultured, “TM7x,” was isolated from the human oral cavity in 2015
(45). TM7x is an obligate epibiotic parasite on Actinomycetes odontolyticus XH001 (45,
46), confirming earlier hypotheses that these organisms may be heavily reliant on others
for growth (47). TM7x masks a proinflammatory response when incubated with its host
and bone marrow macrophages, as compared to host alone, and enhances biofilm
formation when grown with its host (45, 48).
In addition to traditional approaches for culturing novel microorganisms of the
human oral cavity, newer technologies have emerged to facilitate further cultivation of the
uncultured. Many organisms in the human oral cavity have a biofilm lifestyle where
species grow and interact in complex ways resulting in strict interdependencies where
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growth may only occur in a community (49, 50). In-vitro biofilm models can be employed
to grow stable, reproducible, communities that harbor uncultured microorganisms. One
such example resulted in the growth of 51 uncultured oral taxa including a TM7 (51).
Another example is the use of microfluidics, microdroplets, and artificial teeth to simulate
the natural environment and allow species to interact as they would in the oral cavity to
support their growth (52-54).

Sulfate Reducing Bacteria
As periodontitis leads to the formation of deep subgingival pockets, this allows
proliferation of anaerobic microorganisms. Sulfate-reducing bacteria (SRB) have been
detected in periodontal pockets (55) and implicated in other diseases such as ulcerative
colitis (56). Inherently SRB could be involved in such destructive diseases due to the
effects of their metabolic by-products (33, 57) such as hydrogen sulfide that results from
dissimilatory sulfate reduction. SRB are not abundant members of the oral microbial
community, with the most common being species of Desulfovibrio. Isolates of
Desulfovibrio fairfieldensis have been associated with periodontitis (55) while cultureindependent studies have linked the SRB genus Desulfobulbus with periodontal disease
in the oral cavity (23, 58, 59).
Approximately eleven environmental Desulfobulbus species have been isolated
and formally characterized to date (60-67). A single Desulfobulbus OTU exists within the
human oral cavity (HOT041). It is generally present at abundances below 1% of the total
microbial community (7, 58) but in periodontitis can reach levels as high as 2% (58).
Environmental Desulfobulbus species are of particular interest due to their ability to
methylate mercury producing a powerful neurotoxin (68). Should oral Desulfobulbus
HOT041 be able to produce methylmercury this could have significant health implications.
Cultivation of host-associated Desulfobulbus and its comparison to environmental
Desulfobulbus would provide important insights into the evolution of this genus and in
identifying whether anaerobic sulfate-reducers merely persist in disease sites or are
capable of actively contributing to disease.
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Candidate Phylum TM7 Bacteria
As mentioned previously, the human oral cavity is home to three candidate phyla
lineages of bacteria: TM7, GN02, and SR1. The TM7 phylum (Candidate Division
Saccharibacteria) is ubiquitous and is found in environments ranging from arctic regions
(69), sediments (47, 70), wastewater (71), bioreactors (44, 72, 73), and the human body
(28, 29, 45, 74, 75). The first identification of this bacterium was in 1996 when clone
sequences were prepared from a peat bog in Germany (76, 77). However, their clone
‘TM7’ represented a solitary deep rooting phylogenetic lineage and no inferences could
be made concerning its role in the environment. Hugenholtz et al. performed the first
targeted study of the TM7 phylum in 2001 (73) in which they used new and existing 16S
rRNA gene sequences from environmental samples to garner a more robust phylogenetic
analysis of these bacteria. This study greatly expanded our view of TM7 phylogeny (73).
The TM7 phylum still remains an enigmatic lineage of bacteria to this day with slow strides
being made in their study.
Recently, deep-sequencing community analysis revealed TM7 bacteria to be
enriched in disease samples relative to non-disease samples. Further genomic
investigation identified potential virulence factors encoded in TM7 genomes, connecting
genotype to a potential disease function (78). Generally present at below 1% of the
healthy oral community (29, 70), TM7 abundance can increase in periodontal bacterial
communities (29, 78). The advancement of whole genome sequencing has continued to
provide a more robust look at TM7 bacteria (28, 70), identifying over a dozen lineages of
TM7 in the oral cavity and noting the average size of TM7 genomes being close to the
lower limit of life for free-living bacteria (44). Partial and completed TM7 genomes (28,
70) seem to suggest TM7 have limited metabolic potential even in free-living
environments. Genome streamlining and reduction can occur as bacteria transition from
free-living to host-associated environments. This often results in restricted host range and
in some cases the acquisition of pathogenicity traits (79-81), but limited knowledge can
be acquired from just sequencing analysis alone. More unique genomes representing
specific and diverse OTUs from host-associated environments are desirable and without
more cultured representatives, TM7 adaptation to the oral cavity and potential role in
disease remains unknown.
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Non-bacterial Diversity of the Human Oral Cavity
Many studies have focused on the highly diverse communities of bacteria that
reside in the human microbiota. However, all branches of life are present including fungi,
archaea, and viruses. This varies by body site where some specialized niches may harbor
none (i.e. subgingival microbiome (24)). Of the HMP dataset, only 0.01% of sequences
aligned to fungal genomes (82). The most abundant fungi identified in human stool
samples is Saccharomyces (82) while for the skin it is Malassezia (83), and for the oral
and vagina it is Candida (84, 85). Many fungi from the human microbiome have cultured
representatives at the genus level but cultivation of these different groups is inconsistent
due to variability regarding which species colonize which individuals and their potential
transience (82). For example, in 2010 one of the first studies to look at uncultured fungi
within the oral cavity identified 74 culturable and 11 non-culturable fungal genera (85).
However 39 genera occurred only once among the 20 patients analyzed emphasizing
how much variability occurs between individuals (85). Continued advancement in
metagenomics and single-cell genomics can aid in further exploration of fungi that lack
uncultured or unsequenced relatives (86, 87).
Archaea are an even more underexplored component of the human microbiome;
with many uncultured representatives and none known to cause disease, although some
associations have been made (88). The most abundant archaea detected and perhaps
the best studied, are the methanogenic archaea (89) hypothesized to be keystone
species that play crucial roles in overall community composition (reviewed in (90)). Of the
methanogenic archaea, five have been isolated from either fecal samples or the oral
cavity (90). Methanobrevibacter oralis is the most dominant oral archaeon (91).
Methanogenic archaea form syntrophic relationships with other bacteria and these
interspecies dependencies may result in the recalcitrance of other bacteria that depend
on archaeal partner metabolic byproducts for their own metabolism (91). Despite some
progress made in the cultivation of archaea, there is much unexplored diversity to still
uncover.
Perhaps the most difficult components of the human microbiome to study is the
viral portion (or the virome) in part because of the lack of common markers for viruses,
the variability in their genomic content (i.e. DNA vs RNA viruses), and limited reference
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material. The human microbiome harbors an estimated number of 10 viruses for every 1
bacterial cell (92), with many viruses residing in the oral cavity, gut, vagina, and skin. The
majority are bacteriophages (93-96). The skin and oral cavity have relatively stable
viromes (94, 95) rather than being highly transient at these exposed locations. Such
sequencing analyses can detect virus-like-particles and provide insight into possible
functions of the virus community.
As we continue to learn more about the bacterial portion of the human microbiome,
we further appreciate the tight communities they form with each other as well as how their
interactions with fungi, archaea, and viruses may help shape their interactions with the
human host. More work is required to fill databases and culture collections to continue to
advance our understanding of the diverse microorganisms of the human microbiome. As
cultivation-dependent and -independent approaches continue to advance, no branch on
the tree of life may remain untouched.

Research Objectives
Despite advances in both cultivation-independent and cultivation-dependent
studies of the human microbiome, many microorganisms remain uncultured. This results
in a lack of hypothesis-driven experimentation regarding their role in human health or
disease. The work described in this dissertation collectively aims to overcome this barrier
and bring previously uncultured microorganisms into laboratory cultures by refining
traditional methodologies and also developing new approaches (Figure 1.1).
In Chapter 2 I aimed to isolate and characterize the human oral Desulfobulbus, a
sulfate reducing bacterium for which single cell genomic data were previously obtained in
our laboratory (33). This particular organism has been linked to periodontal disease and
single-cell genomic analysis has identified potential virulence factors that may play a role
in disease progression. Oral Desulfobulbus has evaded cultivation and it has been
unknown whether this bacterium merely persists in subgingival pockets or actively
contributes to a proinflammatory environment. Chapter 2 describes the isolation and
characterization of Desulfobulbus oralis sp. nov. and provides evidence of the potential
virulence of this organism.
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Figure 1.1. Graphical abstract outlining cultivation-dependent and cultivationindependent approaches for the study of human microbiome samples. Methods such as
single cell genomics and metagenomics can elucidate the potential functions
microorganisms have in their environments (left) and can be used to formulate
hypotheses about how to culture them. Coupling this with traditional microbiology (right)
we can uncover specific species interactions that cannot be inferred from sequencing
alone.
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During the isolation of D. oralis in Chapter 2, I uncovered clues as to why this
organism has been recalcitrant to cultivation. D. oralis is dependent on Fusobacterium
nucleatum by-products for growth. Chapter 3 investigates this dependency by using
metabolomics facilitated by mass spectrometry to understand the metabolic by-products
of F. nucleatum. As other bacteria have been shown to also have this dependency,
identifying metabolites produced by F. nucleatum may assist in the cultivation of other
currently uncultured microorganisms of the human microbiome.
Finally, to begin to understand other oral lineages that lack cultured
representatives, Chapter 4 details a “reverse-genomics” cultivation approach using TM7
bacteria as a test case. TM7 bacteria are phylogenetically diverse in the oral cavity (over
a dozen distinct OTUs) with only one representative cultured to date (a single Group 1
TM7 out of the 6 identified clades). We demonstrate the utility of this approach by
culturing three new TM7 species and by sequencing 23 single-cell TM7 genomes.
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CHAPTER TWO - Insights into the evolution of host association
through the isolation and characterization of a novel human
periodontal pathobiont, Desulfobulbus oralis
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Abstract
The human oral microbiota encompasses representatives of many bacterial
lineages that have not yet been cultured. Here we describe the isolation and
characterization of previously uncultured Desulfobulbus oralis, the first human-associated
representative of its genus. As mammalian-associated microbes rarely have free-living
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close relatives, D. oralis provides opportunities to study how bacteria adapt and evolve
within a host. This sulfate-reducing deltaproteobacterium has adapted to the human oral
subgingival niche by curtailing its physiological repertoire, losing some biosynthetic
abilities and metabolic independence, and by dramatically reducing environmental
sensing and signaling capabilities. The genes that enable free-living Desulfobulbus to
synthesize the potent neurotoxin methylmercury were also lost by D. oralis, a notably
positive outcome of host association. However, horizontal gene acquisitions from other
members of the microbiota provided novel mechanisms of interaction with the human
host, including toxins like leukotoxin and hemolysins. Proteomic and transcriptomic
analysis revealed that most of those factors are actively expressed, including in the
subgingival environment, and some are secreted. Similar to other known oral pathobionts,
D. oralis can trigger a pro-inflammatory response in oral epithelial cells, suggesting a
direct role in the development of periodontal disease.

Importance
Animal-associated microbiota likely assembled as a result of numerous
independent colonization events by free-living microbes followed by co-evolution with
their host and other microbes. Through specific adaptation to various body sites and
physiological niches, microbes have a wide range of contributions, from beneficial to
disease causing. Desulfobulbus oralis provides insights into genomic and physiological
transformations associated with transition from an open environment to a host-dependent
life style and the emergence of pathogenicity. Through a multi-faceted mechanism
triggering pro-inflammatory response, D. oralis is a novel periodontal pathobiont. Even
though culture-independent approaches can provide insights into the potential role of the
human microbiome “dark matter”, cultivation and experimental characterization remain
important to studying of the roles of individual organisms in health and disease.

Introduction
Periodontitis is one of the most prevalent human diseases around the world.
Moderate stages affect more than half of adults while the severe form, involving tooth
loss, occurs in 10-20% of the population (97, 98). Periodontitis has a complex
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polymicrobial etiology with current models implicating synergistic and dysbiotic
interactions between members of the gingival microbial community (including species
present at low abundance) as the disease onset (16, 21, 99, 100). Plaque biomass
accumulation followed by changes in the composition of the microbiota lead to and
advance gum inflammation (gingivitis). Further increase in microbial biomass,
exacerbated by poor hygiene and genetic predisposition sustain additional shifts in the
microbial community composition, which becomes increasingly anaerobic in deepening
periodontal pockets as periodontitis develops (100). At that stage, microbial signaling,
with some species playing keystone disease roles, interferes with the normal host
immune defense and causes a persistent inflammatory response, resulting in tissue and
bone loss (101, 102).
Among the first bacteria implicated in the etiology of periodontal disease were
Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia (103). More
recent microbiome sequencing and disease association studies suggest that a much
larger number of species (from over 700 that constitute the human oral microbiome) likely
play a role in the development of oral disease, highlighting that periodontitis has a
complex, polymicrobial etiology (20, 78, 104, 105). Some species are potentially
beneficial, contributing to a healthy oral homeostasis, while others are associated with
various stages of gingivitis and periodontitis, potentially acting as keystone species and/or
virulent components of the disease-inducing microbiota (100). Studies with pure cultures,
defined communities in vitro and in animal models have revealed pro-inflammatory
characteristics and interspecies signaling that result in community shifts and a host
response leading to tissue destruction (106, 107). However, approximately one-third of
the oral microbial species-level taxa are still uncultured, including dozens of diseaseassociated lineages (108). To better understand the complex interactions between oral
bacteria and their role in the transition from health to disease, cultivation remains a critical
initial step (108).
Based on rRNA relative sequence abundance, Desulfobulbus sp. HOT41
(Deltaproteobacteria) has been one of the uncultured bacteria strongly associated with
advanced periodontitis (104, 105). Deltaproteobacteria have low taxonomic diversity in
the human microbiome and other species have been linked, based on relative
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abundance, to either oral disease (Desulfomicrobium orale and Desulfovibrio
fairfieldensis) (109, 110) or to intestinal and gynecological disorders (Desulfovibrio piger
and Desulfovibrio intestinalis) (111-113). As with other oral species, it has remained
unclear if those organisms play a role in the etiology of periodontitis or their increased
abundance is a consequence of the disease state, with deep subgingival pockets favoring
the proliferation of strict anaerobes. No host-associated species of Desulfobulbus has
been cultivated so far, although multiple free-living relatives have been isolated and
characterized from aquatic and sediment samples (60-62, 65-67, 114). All free-living
Desulfobulbus species are sulfate reducers, strict anaerobes, largely prototrophic, and
use a variety of electron donors and acceptors. Adaptation to a host-associated lifestyle
provides relative environmental stability and close interaction with other host-recruited
species.

These

factors

often

lead

to

genome

reduction,

metabolic

co-

dependence/specialization, and sometimes emergence of pathogenicity through lateral
gene transfer (114-116). Previous single-cell genomic data suggested Desulfobulbus sp.
HOT41 is capable of sulfate reduction (33), which we used here to selectively enrich for,
isolate, and characterize that organism as the first host-associated member of the
Desulfobulbus genus. Its physiological, genomic, and immune modulatory characteristics
provide new insights into adaptation to the human host-associated lifestyle and the
emergence of pathogenicity.

Results and Discussion
Enrichment cultures and isolation of a human oral Desulfobulbus in pure
culture. We established culture enrichments of sulfate-reducing bacteria using human
oral subgingival samples collected from an individual with chronic periodontitis. Upon
repeated passage in sulfate-lactate based medium we obtained a stable, simple
community composed of Fusobacterium nucleatum, a common human oral bacterium,
and Desulfobulbus sp. HOT41. The composition of this co-culture was characterized
using small subunit rRNA amplicon sequencing (Illumina MiSeq), fluorescence in situ
hybridization (FISH), and quantitative PCR (qPCR) revealing that F. nucleatum
outnumbered Desulfobulbus sp. HOT41 by five to ten-fold in stationary phase (Figure
2.1a,b). During time course co-cultivation experiments, the growth of Desulfobulbus sp.
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Figure 2.1. Desulfobulbus sp. strain HOT041 (D. oralis) in coculture with Fusobacterium
nucleatum and in pure culture. a. FISH using fluorescent oligonucleotide probes specific
for Deltaproteobacteria (green) and universal Bacteria (red). b. Growth of Desulfobulbus
sp. strain HOT041 and F. nucleatum in coculture monitored by species-specific qPCR
(with error bars based on three biological replicates). (c and d). Scanning electron
micrographs of the D. oralis isolate. The arrowheads point to membrane vesicles.
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HOT41 always exhibited a lag phase but growth continued for days after F. nucleatum
reached stationary phase. As initial experiments to isolate Desulfobulbus sp. HOT41 in
pure culture by serial dilutions were unsuccessful, we hypothesized that the organism
required metabolites produced by F. nucleatum in the co-culture and, because
microscopic analysis did not reveal a stable physical interaction between the two
organisms, that Desulfobulbus sp. HOT41 could acquire them directly from the co-culture
medium. Such dependence on metabolic co-factors produced by other community
members, including Fusobacterium, has been described for other oral bacteria as well
(39, 41, 117). We therefore supplemented fresh culture medium with filter-sterilized
medium from stationary-phase co-cultures (cell-free spent medium, CFS) and, by
applying three successive rounds of dilution to extinction, we obtained pure cultures of
Desulfobulbus sp. HOT41. Purity was determined microscopically by FISH and by deep
rRNA amplicon and genome sequencing. The isolate was named Desulfobulbus oralis,
its SSU rRNA being 99.6% identical to Desulfobulbus sp. HOT41 clone R004 (118).
Physiological characterization of D. oralis. D. oralis is Gram-negative, nonmotile and non-sporulating, with rod-shaped cells 1-2 μm in length and 0.3 μm in
diameter. Cells usually occur singly or in pairs although sometimes form longer chains.
In scanning electron micrographs we observed the presence of outer membrane vesicles
(25-50 nm in diameter) on some cells (Figure 2.1c,d). Such vesicles, common in Gramnegative organisms including known oral pathobionts, have been shown to play important
roles in interspecies interaction and to contain factors that trigger an inflammatory
response (119, 120).
For routine cultivation, we grew D. oralis anaerobically at 37°C in a minimal defined
liquid medium with lactate as the sole carbon and electron source and sulfate as the
electron acceptor, supplemented with 5% (v/v) F. nucleatum CFS. No growth occurred in
the presence of trace levels of oxygen or in the absence of F. nucleatum CFS. We found
that the soluble, growth-promoting component(s) of CFS could not be inactivated by
heating or protease treatment and could not be substituted by defined supplements such
as vitamins, amino acids, volatile fatty acids, siderophores or complex nutrients (yeast
extract, peptone, brain-heart infusion), individually or in combinations. Therefore, the
nature of the critical component(s) provided to D. oralis by F. nucleatum remain unknown
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but such requirement has been documented for other human oral bacteria as well,
including the Chloroflexi sp. HOT-439 (41) and Fretibacterium fastidiosum (39). Within
the oral cavity, this type of interspecies dependence has become evident and is likely the
main reason for recalcitrance to cultivation of many yet-uncultured species that, likewise,
have lost the ability to synthesize a number of compounds and therefore must rely on
other members of the microbiota (108, 121). CFS from a type strain of F. nucleatum
(ATCC 23726) also supported the growth of D. oralis, indicating its physiological
dependence is not restricted to the strain it co-enriched with, although we have not
extended that analysis to additional strains or species.
D. oralis is quite limited in the types of electron donors and acceptors it can utilize
as an energy source for respiratory growth. Lactate and pyruvate are the only electron
donors capable of being respired, while only sulfate or thiosulfate served as electron
acceptors, out of all combinations tested (Table A2.1) (all additional material appears in
the Chapter Appendix). Lactate was utilized with stoichiometric (1:1) production of acetate
as the metabolic byproduct (Figure 2.2a) and the release of sulfide. Respiratory growth
on pyruvate was very weak. We also tested D. oralis for its ability to ferment organic
substrates in the absence of an electron acceptor (sulfate respiration). Growth was
supported by pyruvate and weakly by amino acids but not by lactate, glucose, mucin, or
peptone. Pyruvate was fermented to acetate and propionate in a 2:1 ratio (Figure 2.2b).
In the subgingival space, sulfate could originate both from the blood and serum, where
its concentration is relatively low (0.15mM) (122), but also a result of the connective tissue
and bone breakdown during periodontal disease progression (122, 123). Lactate and
pyruvate are released by other members of the oral microbiota and are important nutrient
sources within the microbial oral biofilm (e.g. (124)). Therefore, we expect that D. oralis
grows in vivo both by lactate-sulfate respiration and by pyruvate fermentation, depending
on the local microenvironment and disease state. D. oralis expands therefore the list of
confirmed sulfate reducers in the oral cavity that includes species of Desulfovibrio and
Desulfomicrobium. Sulfate reducers have long been associated with periodontal disease
and their abundance correlated with disease severity (125). The availability of nutrients
and especially sulfate may be limiting factors in their proliferation, as these organisms are
specialized users of that terminal electron acceptor (57).
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Figure 2.2. Growth of D. oralis by respiration and fermentation. a. Time course cultivation
using sulfate and lactate as the electron donor-acceptor pair, with the release of acetate.
b. Substrate utilization and metabolic by-products of pyruvate fermentation. The error
bars are based on three culture replicates.
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Comparative physiology and emergence of host association within the
Desulfobulbus genus. Host-association leads to a reduced metabolic versatility, as the
chemical and biological environment is relatively stable. This was evident as we
compared the ability of several Desulfobulbus species to utilize various growth substrates
(Table A2.1). All of the free-living isolates are able to utilize a wider range of substrates
as electron donors and acceptors and for fermentation than D. oralis. Notably, propionate
respiration and lactate fermentation, common traits among all free-living Desulfobulbus,
have been lost in D. oralis. Within the Desulfobulbus genus, host association is not
restricted to humans, as closely related uncultured species have been detected in the
oral microbiota of domesticated dogs (126) and cats (127). We performed a phylogenetic
analysis using full length SSU rRNA gene sequences, which suggested that mammalian
host association was likely the result of an ancestral oral colonization by a free living
Desulfobulbus, most closely related to D. oligotrophicus (Figure 2.3). Additional
sequences from other mammalian lineages as well as cultivation of other host-associated
Desulfobulbus would be required to better understand the co-evolution of these bacteria
with their hosts.
Genome sequencing, annotation, and metabolic reconstruction. We obtained
the complete genome sequence of D. oralis using long read sequencing (PacBio). The
assembly resulted in a single contig (>600 fold coverage), which was circularized as a
single chromosome of 2,774,417 base pairs, with a G+C content of 60%. We further used
mapping of Illumina short reads to correct any potential sequence and assembly errors.
Gene prediction and annotation was performed in both Genbank and IMG and was
supplemented with annotations based on Pfam, KEGG and eggNOG (128) (Dataset
S2.1). The D. oralis genome encodes 2,395 proteins (GenBank), 51 tRNAs, and has 2
rRNA operons. A slightly larger number of proteins were predicted with IMG (2442) and
we identified the differences as small hypothetical proteins and mobile genetic elements
(transposases).
When compared to genomes of environmental Desulfobulbus species (Table
A2.1), the genome of D. oralis is 30-50% smaller. There is also limited gene synteny
based on comparison with the only closed genome of an environmental Desulfobulbus
(D. propionicus) (Figure 2.4) suggesting numerous chromosomal rearrangements
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Figure 2.4. Genomic comparison of D. oralis and D. propionicus. Matching orthologs are
connected by internal arc lines, the color scale indicating the degree of pairwise sequence
identity at the protein level. External tick lines indicate genes in each genome that contain
protein domains enriched (blue) or depleted (red) in D. oralis (based on data in Data Set
S2). The outer histograms (light blue) indicate the relative abundance of each detected
protein in D. oralis cells (bottom) or culture medium (top). Secreted proteins significantly
enriched in the medium are identified and indicated by purple asterisks and lines.
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associated with genomic fragmentation. For metabolic reconstruction, we combined
assignments from IMG, KEGG’s BlastKOALA, and MetaCyc, with similarity searches,
domain architecture analyses, sequence alignments, and phylogenetic reconstruction for
comparisons of enzymes and pathways with other sulfate reducers and oral bacteria.
As physiological characterization of D. oralis revealed streamlining and loss of
some of the free-living Desulfobulbus respiratory and fermentative capabilities, the first
objective in metabolic reconstruction was to predict the bioenergetics and carbon flow
associated with respiratory versus fermentative growth in the oral environment. The
dissimilatory sulfate reduction pathway (129), common to all Desulfobulbus species,
could be reconstructed based on the D. oralis genome and is proposed to follow
transformations represented schematically in Figure 2.5. Sulfate enters the cell via a SulP
permease and is activated by adenylation via a sulfate adenylyl transferase (Sat). The
resulting

pyrophosphate

is hydrolyzed

by a

manganese-dependent inorganic

pyrophosphatase (ppaC), which drives the otherwise endergonic activation step. The
adenosine 5’-phosphosulfate is converted to sulfite by APS reductase (Apr), a
heterodimeric iron–sulphur flavoprotein complex, which receives electrons from a
membrane-bound oxidoreductase complex (QmoABC) that interacts with the quinone
pool as part of the energy conservation cycle (130). Sulfite is further reduced to sulfide
by the dissimilatory sulfite reductase (Dsr), a large enzyme complex that includes
cytoplasmic, membrane anchored and periplasmic subunits including cytochromes b and
c, quinone interacting domains, and iron sulfur centers that mediate electron transfer and
proton translocation (Figure 2.5).

Another energy-conserving membrane complex

present in D. oralis shares homology with the membrane-bound NADH dehydrogenase
complex Nuo and is encoded by an eleven-gene cluster. However, the NuoEFG subunits,
responsible for oxidizing NADH, are missing, so the complex may oxidize a different
electron donor, such as reduced ferredoxin, similar to other sulfate reducers (131). The
Nuo complex is complete in D. propionicus.
A cytoplasmic Hdr–Flx complex that can perform an alternative mode of energy
conservation, flavin-based electron bifurcation (FBEB)(132) is present in D. oralis but
absent in free living Desulfobulbus. The complex appears to have originated from a
Desulfovibrio by horizontal gene transfer (HGT) and is most closely related to that of the
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Figure 2.5. Metabolic reconstruction of D. oralis, with emphasis on membrane processes,
energy conservation, and pathogenicity potential. Selected genes encoding enzymes,
complexes, and other proteins proposed to function in such cellular processes are
indicated by numbers in red, corresponding to GenBank genes in Data Set S1. The
putative EtfAB-Ldh complex is depicted in gray.
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human oral D. fairfieldensis. The FlxABC complex has FAD, NAD(P)-binding sites, and
an iron-sulfur center, representing a distinct type of NAD(P)H dehydrogenase, which was
proposed to oxidize NAD(P)H using both ferredoxin and a high redox disulfide center
(DsrC) as electron acceptors (133). The reverse reaction, NAD+ recycling to NADH, can
be coupled in environmental Desulfovibrio with aldehyde conversion to ethanol during
pyruvate fermentation, using electrons coming from reduced ferredoxin through HdrABC
(133). While we did not detect alcohol production by D. oralis, a related aldehyde
detoxification process could occur through an NADPH-dependent alcohol dehydrogenase
(CAY53_10125), most closely related to genes from human and animal-associated
Actinobacteria. The interconversion between reduced and oxidized forms of NAD(H) and
NADP(H) is performed by NfnAB, also an electron-bifurcating, ferredoxin-dependent
flavoprotein. Another complex with a role in detoxification is the cytochrome c-containing
nitrite reductase, NrfAH. This membrane complex, present in pathogenic bacteria,
detoxifies nitric oxide produced by host cells as a defense mechanism against bacterial
invasion (134).
Oxidation of lactate to pyruvate during sulfate respiration is catalyzed by a
peripheral membrane associated multisubunit lactate dehydrogenase (LutABC) that uses
the menaquinone pool as the electron acceptor. The complex is encoded in the same
operon with a lactate permease (LutP) and appears to have been acquired from host
associated Desulfovibrio, lacking close homologues in environmental Desulfobulbus.
Lactate is an important shared substrate among many oral bacteria and the acquisition
of the Lut system by D. oralis likely reflects an important adaptation to this environment
following colonization. Pyruvate is further decarboxylated to acetyl-CoA by a
pyruvate:ferredoxin oxidoreductase, generating reduced ferredoxin. D. oralis has lost
both phosphate acetyl transferase and acetate kinase and we hypothesize that acetate
release occurs via CoA transfer by a succinate:acetate-CoA transferase, that was likely
acquired from a host-associated Campylobacter (Figure A2.1), followed by transphosphorylation by succinate thiokinase and nucleoside diphosphate kinase (Figure 2.5).
This pathway is consistent with the observed 1:1 stoichiometry of lactate conversion to
acetate (Figure 2.2a). It would result in the production of one ATP per lactate via
substrate level phosphorylation and an additional amount of ATP via sulfate respiration

29

that depends on the number of protons translocated across the cytoplasmic membrane
and the coupling number of the F0F1 ATPase.
For free-living Desulfobulbus, lactate can also be fermented. An electronbifurcating, cytoplasmic lactate dehydrogenase-flavoprotein complex (Ldh-Etf) oxidizes
lactate to pyruvate by coupling the endergonic NAD+-dependent oxidation of lactate to
the exergonic electron transfer from reduced ferredoxin to NAD+ resulting in the oxidation
of one ferredoxin and the production of 2 NADH (135). For every three pyruvate produced
from lactate, one is converted to acetate, generating reduced ferredoxin and an ATP by
substrate level phosphorylation, while two more pyruvate molecules are reduced to
propionate. This would result in an expected product ratio of 2:1 propionate to acetate
(136). Even though we did not detect fermentative growth on lactate, D. oralis has a
potential Ldh-Etf complex encoded in its genome. It is therefore possible that it may
ferment lactate in vivo, and that the inability to do so under pure culture conditions is due
to insufficient protein expression. In fact, based on whole cell proteomic analysis (detailed
below) we found that the Ldh complex subunit was present at extremely low levels
(~0.001% of the proteome), two orders of magnitude below that of the Etf subunits. In the
absence of lactate fermentation, D. oralis can nevertheless ferment pyruvate through the
propanoate cycle. In this case, for every three pyruvate molecules, two can be converted
to two acetate molecules with the generation of two ATP and two reduced ferredoxins,
while one additional pyruvate serves as an electron acceptor and is reduced to
propionate. This results in the expected ratio of 1:2 propionate to acetate during pyruvate
fermentation, consistent with our observed results (Figure 2.2b).
D. oralis has incomplete pathways for the biosynthesis of several amino acids
(serine, threonine, cysteine, tyrosine, and phenylalanine) as well as for biotin,
molybdenum cofactor, and cobalamin. Amino acid and vitamin auxotrophies are common
among bacteria that live within complex communities such as the oral microbiota.
However, D. oralis has additional, yet unidentified dependencies; simple supplementation
with amino acids, peptides and/or vitamins did not relieve the requirement for the
Fusobacterium culture filtrate. Nucleotide biosynthesis and conversion appears fully
functional and D. oralis can also synthesize a variety of fatty acids and sugars for
membrane, peptidoglycan, and lipid A assembly. Future elucidation of this nutritional
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requirement may enable more rapid isolation of other fastidious microorganisms from
human microbiomes.
Genomic fingerprints for adaptation to a host-associated environment and
potential pathogenicity. Desulfobulbus oralis has a reduced genome which displays
limited conserved gene synteny when compared to its closest sequenced free-living
relative (Figure 2.4), as well as evidence for both gene loss and gene gain. Aside from
becoming dependent on exogenous amino acids and vitamins, gene loss has affected
hydrogenases, ferredoxin oxidoreductases, cytochromes, the dissimilatory nitrate
reductase, and pyruvate kinase. This restricts D. oralis from utilizing a wider range of
electron donors and acceptors and fermentation substrates that are not present at high
concentrations in the oral environment (nitrate, short chain fatty acids, and alcohols). As
very few organisms from the oral microbiota are capable of sulfate respiration, the
restricted energy metabolism in D. oralis may reflect its adaptation to a metabolic niche
in which there are few competitor species, with no selection to maintain metabolic
versatility typical of free living Desulfobulbus species.
Following host colonization, cohabitation with bacteria not present in open
environments presents the opportunity for horizontal gene transfer and acquisition of
physiological traits that are absent in free-living species. Horizontal gene transfer is an
important factor influencing the human oral microbiota and its individual species’ positive
and negative interactions with the host (137, 138). Based on sequence similarity and
phylogenetic analyses, we found evidence for multiple horizontal gene transfer events.
Sixty percent of the D. oralis genes have their closest homologs in the genomes of freeliving Desulfobulbus and potentially can be regarded as inherited from the ancestral
lineage that colonized the mammalian oral environment (Dataset S2.1). Approximately
200 predicted protein-encoding genes (~8% of the genome) have no distinguishable
homologues, most of them being quite short and without recognizable protein domains.
Out of the remaining genes, >250 (10%) are most closely related to homologues from
other

Deltaproteobacteria

and

have

the

oral Desulfovibrio

fairfieldensis

and

Desulfomicrobium orale as the top hits, suggesting they might have been acquired from
such physiologically-related lineages. Among those genes are clusters encoding for a
variety of transporters and energy conservation complexes (lactate dehydrogenase,
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glycerol-3-phosphate dehydrogenase, heterodisulfide reductase). Other potential
horizontally acquired genes include transporters, drug and antibiotic efflux pumps,
hydrolases, glycosyl transferases involved in cell membrane biosynthesis, CRISPR
system proteins, and other enzymes and regulators from a wide range of oral bacteria,
including Actinomyces, Streptococcus, Porphyromonas, Tanerella, Prevotella, Neisseria,
and Campylobacter (Figure A2.1). As far as gene absence, it was notable to find that the
hgcA and hgcB genes, present in all environmental Desulfobulbus identified so far (139),
have been lost in D. oralis. Those genes encode a corrinoid iron-sulfur protein (HgcA)
and a ferredoxin (HgcB) that are responsible for the microbial synthesis of methyl
mercury, a potent neurotoxin (140). While the biological role of HgcA-B is still unknown,
the finding that D. oralis has lost that biochemical potential represents a highly significant
positive outcome of adaptation to the oral microbiota, especially considering mercury
amalgam tooth fillings continue to be used and are present in many individuals.
To get a more quantitative estimate on gene family loss and gain in the D. oralis
genome relative to its free-living relatives, we performed functional abundance profile
analyses in IMG (Dataset S2.2). At the protein domain (Pfam) level, several categories
of transposases and other mobile elements (integrases and endonucleases) are highly
enriched in D. oralis as compared to other Desulfobulbus. Phylogenetically, many of those
genes appear to be related to Desulfomicrobium and may reflect multiple genetic
exchanges between these two related sulfate reducers in the oral microbiota. At the gene
family level (COG), aside from mobile elements, COG families involved in membrane lipid
biosynthesis and transporters are enriched. Considering that D. oralis relies on
exogenous amino acids, it is not unexpected to see that amino acid and peptide ABC
transporters are at higher abundance than in other Desulfobulbus, and some of the genes
were likely acquired from other oral bacteria by HGT. Four genes (9825, 9840-9855) that
encode members of an ankyrin repeat protein family that may be involved in the
interaction with human cells (141), absent in free-living Desulfobulbus, were also
apparently acquired from oral Synergistetes (Figure A2.1).
With respect to gene loss, the most pronounced difference between D. oralis and
its free-living relatives were observed in the category of signal transduction and gene
regulation (Dataset S2.2). Indeed, this functional category shows the steepest
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dependence on the total number of genes in bacteria and archaea (142); however, D.
oralis presents significant deviation from the general trend. While the number of genes in
D. oralis is only 30% smaller than that in a free-living D. propionicus, the number of signal
transduction genes in D. oralis is 4.5 times smaller: 72 genes (Dataset S2.3) versus 320
genes in D. propionicus (data from the MiST database (143)). Such deviations were
proposed to reflect particular biological phenomena as well as environmental conditions
in a microbial habitat (144). Thus, we explain a disproportional loss of signal transduction
capabilities in D. oralis as a direct result of adaptation to a much more stable niche, where
constant temperature, pH, and set of nutrients eliminate the need to monitor and respond
to various environmental factors. The absence of swimming motility in D. oralis is yet
another conspicuous example of adaptation to a new environment via gene loss. While
free-living representatives of Desulfobulbus contain a full complement of flagellar genes
and chemotaxis machinery (more than 50 genes), D. oralis lost all of these genes.
However, it retained type IVa pili (TFP) that are essential for active translocation across
solid surfaces, including PilT, a marker gene for TFP-based motility, as well as two
regulatory chemosensory systems that belong to TFP class (Dataset S2.4). Thus, despite
the loss of flagella and chemotaxis, D. oralis is capable of actively navigating toward
beneficial microenvironments within the oral cavity.
As the relatively streamlined metabolism of D. oralis does not suggest it could
provide the human cells with vitamins or other beneficial factors, we searched for potential
genes that could mediate evading the host defense system and a potential role in
pathogenesis. One such candidate gene family encodes eight proteins containing the
Sel1 domain, characteristic of solenoid proteins involved in a variety of signal transduction
processes (145). Three of the D. oralis Sel1 domain proteins are related to proteins that
are involved in the bacterial interaction with human cells including evasion of lysosomal
host defense mechanisms, such as the Legionella LpnE and LidL (146) and yet
uncharacterized proteins from opportunistic pathogens like Neisseria, Haemophilus and
Kingella (147-150) (Figure A2.1). Another relative of those proteins are EsiB (Escherichia
coli secretory immunoglobulin A-binding protein), a pathogenic E. coli marker (151)
confirmed to have host immune modulatory activity by interacting with secretory IgA, thus
leading to inhibition of neutrophil activation and evasion of host defense mechanisms
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(152, 153). This ultimately allows E. coli to avoid clearance by the host’s immune system
and permits further infection. A similar role could be employed by D. oralis to avoid
negative effects of host immune responses in periodontal disease progression allowing
for its proliferation and increase in abundance. D. oralis also encodes genes for
leukotoxin/hemolysin production and export through type I secretion systems.
Leukotoxins belong to the RTX toxin family, broadly distributed among Gram-negative
bacteria and with diverse biological functions. Leukotoxin produced by the periodontal
pathobiont Aggregatibacter actinomycetemcomitans are lethal to human monocytes and
human T lymphocytes in vitro (154, 155) and are a main virulence factor within deep
periodontal pockets in aggressive periodontitis (156-158). Genes encoding other RTX
family homologues include adenylate cyclase/hemolysin, which is the major virulence
factor of Bordetella (159-161), as well as an outer membrane translocation complex
involved in RTX protein processing and export (157). Based on these findings, we
propose that leukotoxin/hemolysin systems of D. oralis, acquired as three distinct operons
(Dataset S2.5), could play roles in the putative pathogenicity of D. oralis by contributing
to host immune evasion, manipulation, and neutralization of defense mechanisms.
Proteomic analysis of D. oralis and its pathogenicity potential. While genome
analysis revealed both native and acquired physiological potential, including the
possibility that D. oralis may play an active role in the etiology of periodontal disease,
simple gene presence is not sufficient evidence to assume that every potential gene
product is actually expressed. We therefore applied a proteomic approach to determine
the relative amounts of every expressed protein within the cell, and whether specific
proteins are released into the extracellular space. Because the main focus was on
proteins that may contribute to pathogenesis, some of which were predicted to be
membrane- anchored while others secreted into the extracellular space, we collected both
cells and filtered culture supernatant. Three separate culture replicates were performed
and the samples for analyses were collected in late log phase.
One of the primary metabolic byproducts of D. oralis sulfate respiration, hydrogen
sulfide, is well-known to trigger an inflammatory response at the leukocyte-endothelium
interface, acting as a primary signaling molecule and synergizing with the proinflammatory action of virulence factors (162, 163). As we wanted to test the synthesis
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and potential pro-inflammatory action of potential virulence factors encoded by D. oralis,
we grew the cells fermentatively, in the absence of sulfate. The whole-cell proteome and
the soluble proteins released into the medium were fragmented and analyzed by bottomup, two-dimensional liquid chromatography tandem mass spectrometry (2D-LC-MS/MS).
A total of 1628 proteins were detected, representing 70% of the predicted proteome
(Datasets S2.1 and S2.6), which is similar to coverage that has been previously obtained
on other organisms with reduced genomes (164, 165). Considering that proteins
containing multiple transmembrane domains are difficult to detect in tryptic digests (here
we detected only 40% of the proteins predicted to contain more than 1 transmembrane
domain) we conclude that a very large fraction of the D. oralis genetic potential (>80%)
was expressed under the tested condition. We also detected most of the putative
virulence factors (hemolysins, leukotoxin, Sel1 proteins) and the proteins involved in their
processing and export. In terms of dynamic range, we detected proteins spanning five
orders of magnitude in relative abundance, from 2% of the cell total cellular proteome
(sulfite reductase) to 2e-5% (a type IV transporter subunit). The most abundant proteins
were determined to be enzymes involved in energy conversion and central metabolism,
protein translation, chaperones, regulators, and several transporters. While the high-level
of proteins involved in respiratory growth may appear surprising, it has been shown in
other sulfate reducers grown under fermentative conditions that the sulfate reduction
pathway is constitutively expressed (166). This indicates that the sulfate reduction
capacity of D. oralis is actively maintained and, when periodontal sulfate levels are
adequate, it may be the primary energy source.
To identify if any of the putatively expressed virulence factors were secreted, we
compared the proteome of whole cells against their secretome. We identified 12 proteins
that were significantly enriched in the culture medium relative to their abundance in whole
cells (Figures 2.4 and 2.6, Dataset S2.6). With the exception of two, a DNA binding factor
and an unknown protein, all others were predicted hemolysin family proteins and were
enriched between 40-100 fold in the culture medium, suggesting that the cells actively
secreted them. In vivo, such secreted hemolysins could diffuse through the epithelial
layer, causing cytotoxicity, lysis, and modulation of the host immune response.
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Figure 2.6. Proteomics and cytokine stimulation implicating D. oralis in proinflammatory
responses. a. D. oralis proteins that are secreted from the cell (indicated in red) based on
enrichment analysis. Only proteins that had at least a 4-fold enrichment and P<0.01
(based on three biological replicates) were considered. The table on the right identifies
those secreted proteins and compares them to their closest homologues in the human
oral microbiota or the free-living Desulfobulbus. b. Cytokine stimulation in oral epithelial
keratinocytes by D. oralis cells. Keratinocytes were incubated with D. oralis cells or with
the medium control for 48h, and cytokine stimulation was measured using a multiplex
bead assay. Each bar represents the mean +/- standard deviation of the mean from
triplicate measurements. Asterisks indicate results significantly different from the
keratinocyte medium-only control: *, P<0.05; **, P<0.01.
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D. oralis cytokine stimulation in oral epithelial keratinocytes. During the initial
stages of periodontal disease there is an acute inflammatory response to some of the oral
microbiota resulting in the recruitment of polymorphonuclear leukocytes stimulated by
host chemokines and/or cytokines, such as IL-8 (167). As inflammation progresses from
acute to chronic, an increase in the production of pro-inflammatory mediators such as IL1β, IL-6, IL-8, and TNF-α by various host cells, including oral epithelial keratinocytes,
results in the recruitment of additional immune cells such as macrophages, T-cells, and
B-cells (167). Various recognized periodontal pathobionts trigger distinct types of
inflammatory responses (168-170) and some (e.g. Porphyromonas gingivalis) can
modulate that by interfering with chemokine production (171).
Based on the finding that D. oralis secretes and has surface associated proteins
(e.g., leukotoxin, hemolysins, esiB-Sel1) that have been shown in other oral bacteria to
be linked to an inflammatory response in periodontitis, we analyzed its ability to induce
pro-inflammatory cytokine production in vitro. We used a human immortalized oral
keratinocyte cell line (OKF6/TERT2), which has been previously used as a model to study
the interaction of oral bacteria with human epithelial cells (169, 172). Cells and filtered
medium from the same D. oralis cultures used for proteomic analyses were applied to
epithelial

cells

in

culture

and

the

production

of

13

human

inflammatory

cytokines/chemokines was measured after 48 hours using bead-based immunoassays.
We detected a significant stimulation of IL-1β release by the keratinocytes exposed to D.
oralis culture filtrate while IL-1β, IFN-α, IFN-γ, MCP-1, IL-6, IL-8, and IL-18 were
stimulated when keratinocytes were exposed to D. oralis cells (Figure 2.6 and Figures
A2.2 and A2.3). The difference in pro-inflammatory responses between culture medium
and whole cells are due to protein concentration differences, as the enriched proteins in
the medium (secreted leukotoxins/hemolysins) and the bacterial cell surface agonists
(e.g. Sel1 proteins, surface pili, LPS) may activate different pathways. The strongest
stimulation was observed for IL-8 (p<0.01). IL-8 is one of the most important chemokines
associated with periodontitis, being elevated at the disease site and attracting neutrophil
polymorphs that further increase pro-inflammatory mediators (167). The observed
release of the other cytokines/chemokines is expected to stimulate B- and T-cell
differentiation as well as attracting macrophages and natural killer cells to the site of
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infection. The absence of stimulation of IL-10 and IL-12, both anti-inflammatory cytokines,
does not support a potential beneficial role of D. oralis. On the other hand, the complex
response triggered by D. oralis in epithelial cells indicates that this bacterium is not merely
a colonizer in the low oxygen deep periodontal pockets but actively participates in
inflammation. During periodontal disease progression the gingival extracellular matrix
breaks down and glycosaminoglycans (GAGs) are released (123, 173). D. oralis encodes
several sulfatases that could liberate inorganic sulfate from GAGs potentially playing an
active role in matrix destruction (174). In addition, the hydrogen sulfide produced by D.
oralis during sulfate respiration can lead to apoptosis in keratinocytes (163, 175) and
further elicits a pro-inflammatory response in oral cells (176, 177). These features
illustrate the capacity of D. oralis to create a dysbiotic oral environment and actively
contribute to the pathogenesis of periodontal disease in a novel and compounded way,
not described for other oral pathogens so far. These results emphasize that cultivation of
novel bacteria, only associated with disease based on sequence data, is important to
begin to fully understand their role in the oral cavity.
Expression of D. oralis pathogenicity genes in periodontitis. A recent clinical
metatranscriptomic study identified Deltaproteobacteria as one of the bacterial lineages
that increase in prevalence and transcriptional activity in periodontitis (178). We therefore
aimed at determining the functional profile of D. oralis and specifically the relative
abundance of its pathogenicity gene transcripts, based on this RNAseq data generated
from oral clinical samples. We determined that in the datasets from three individuals with
periodontitis, the sequences that mapped to D. oralis protein encoding genes (~300025,000 reads) represent 0.1-0.5% of the total number of microbial reads. Even though the
overall coverage of the D. oralis transcriptome by the RNAseq datasets was shallow (<two
fold), across the three datasets >80% of the predicted gene transcripts were detected
(Dataset S2.1), with ~65% of the genes represented by at least two reads. This correlates
with the overall number of proteins we detected in D. oralis grown in pure laboratory
cultures and supports the hypothesis that most genes in this bacterium are expressed
both in vitro and in the natural subgingival environment. While the coverage level was too
low to enable a robust global comparison of the transcriptional versus proteome profile,
we analyzed the relative levels of mRNAs encoding putative pro-inflammatory response-
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inducing proteins. Several of the hemolysin-type genes were amongst the top 50 most
abundant transcripts (0.2-1% of the mapped reads), with four of them being part of a
highly expressed operon (CAY53_915-940) (Dataset S2.5). This indicates that such
factors, which have been linked to inflammatory response in other oral bacteria, are being
actively produced by D. oralis in the subgingival space and likely play a role in the
development and progression of periodontal disease.
Description of Desulfobulbus oralis sp. nov. Desulfobulbus oralis sp. nov.
(o.ra’lis. N.L. masc. adj. oralis of the mouth). Cells are non-motile, non-spore-forming
Gram-negative rods 1-2 μm in length occurring singly, in pairs, and sometimes chains.
Growth occurred at 37°C with optimum pH 7-7.1 under strictly anaerobic conditions, with
cysteine as a reducing agent. D. oralis incompletely oxidizes lactate and pyruvate to
acetate, using sulfate or thiosulfate as electron acceptors and releasing sulfide. The
organism does not utilize citrate, propionate, acetate, hydrogen, formate, succinate,
glucose, fructose, ethanol, propanol, fumarate or malate as electron donors or sulfite and
nitrate as acceptors. In the absence of electron acceptors, pyruvate and amino acids are
fermented while lactate, peptone, mucin, and dextrose are not. Growth requires the
addition of 5% Fusobacterium nucleatum cell-free spent medium (CFS).
D. oralis type strain ORNL was isolated from a human subgingival sample from a
patient with periodontitis at Ohio State University College of Dentistry, Columbus, Ohio.
The genome is represented by a circular chromosome of 2.77 Mbp and with G+C content
of 59.76 mol%.

Materials and Methods
Clinical sample collection. Subgingival biofilm and crevicular fluid was obtained
from a patient with periodontitis at the Ohio State University College of Dentistry. Informed
consent was obtained, under a protocol approved by the Ohio State University IRB
(2007H0064). Following removal of supergingival plaque with gauze, sterile endodontic
paper points were inserted into the gingival sulcus and left for one minute. Afterwards
they were placed into Liquid Dental Transport Medium (Anaerobe Systems, Morgan Hill,
CA) and used for inoculation into primary enrichment medium.
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Microbial cultivation. Primary oral enrichments were passaged (2% v/v) in an
ATCC 1249 modified Baar’s medium containing (per liter): 2g MgSO 4.7H2O, 1g
(NH4)2SO4, 0.5g K2HPO4, 1g CaCl2.2H2O, 5g sodium citrate, 1.17g sodium propionate,
1.17g sodium acetate, 1.5mL L(+)-lactic acid (85% w/v, Sigma), 1g yeast extract, and 0.5
mg resazurin. The medium was degassed with N 2/CO2 (80/20, v/v), sterilized for 15
minutes at 121°C followed by addition of sterile degassed cysteine (1mM final
concentration) and 10mL Fe(NH4)2(SO4)2 5% (w/v) and pH adjustment to 7.2 with 8M
NaOH. Cultures were maintained in 15 mL glass tubes fitted with butyl rubber stoppers,
under N2/CO2 (80/20, v/v) at 37°C for 1-2 weeks. Cell growth resulted in the release of
hydrogen sulfide, which formed a black iron sulfide precipitate and was also detected
using lead acetate indicator paper. Stocks were preserved by freezing at -80°C, after
adding DMSO to 10% (v/v). Cell-free spent medium supernatant (CFS) was prepared by
filtering cultures through two 0.22μm NalgeneTM Rapid-FlowTM sterile filters and
degassing with N2 (100%). Pure cultures were obtained by three successive dilutions to
extinction transfers in liquid medium. For culture enrichments of D. oralis, the medium
was supplemented with 25% (v/v) co-culture CFS. Pure cultures of D. oralis were grown
in a modified Lactate-Baar basal medium containing (L-1 distilled water): 2g MgSO4.7H2O,
1g (NH4)2SO4, 10mM MOPS, 10mM HEPES, 10mM sodium lactate, 0.1% yeast extract,
2.5mM cysteine, and 0.5 mg resazurin 0.5%. The pH of the media was adjusted to 7-7.1
with 8M NaOH, degassed with N2 (100%) and autoclaved for 30 minutes at 121°C. After
cooling, sterile K2HPO4 (0.5M, pH 7) was added to 3mM final and CFS of F. nucleatum
grown in brain-heart-infusion broth (BHI) supplemented with 0.2% glucose was added to
5% (v/v). In subsequent experiments we determined that the addition of yeast extract was
not necessary for growth.
Cellular and molecular analyses. Fluorescence in situ hybridization (FISH) with
the oligonucleotide probes EUB338 (Bacteria) and Delta495a (Deltaproteobacteria) was
performed as previously described (33). For DNA isolation we used proteinase K
digestion followed by phenol-chloroform extraction (164). PCR-amplification of the 16S
rRNA

gene

was

carried

out

using

the

universal

primer

set

27F

(5’-

AGAGTTTGATYMTGGCTCAG-3’) and 1492R (5’-TACGGYTACCTTGTTACGACTT-3’)
or a specific D. oralis set DsbF (5’-AGTTAGCCGGTGCTTCCT-3’) and 1492R.
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Amplification with Lucigen 98HotStart Supermix used the following thermal profile: 94°C
for 3 minutes, followed by 32 cycles of 94°C for 20 seconds, 60°C for 30 seconds, 72°C
for 90 seconds, and a final extension of 72°C for 5 minutes. Following purification, the
PCR products were sequenced directly using Sanger chemistry (ABI 3730) or were first
cloned into pCRTM2.1-TOPO (Invitrogen, Carlsbad CA, USA). Sequence data was
analyzed using Geneious v.10 (179) and confirmed the in silico-inferred primer specificity.
To quantitatively determine the co-culture composition, we developed a qPCR assay
using

16S

rRNA

gene

primers

specific

for

F.

nucleatum

(5’-

CAGCGTTTGACATCTTAGGA-3’ and 5’-ATCGTAGGCAGTATCGCAT-3’) and for D.
oralis

(5’-GGTGGTGCCTTCTTTGAA-3’

and

5’-TTCCTCCGGTTTGAC

ACC-3’).

Amplification was with BioRad iQ SYBR Green Supermix in a CFX96 TM Real-Time C1000
thermal cycler (Bio-Rad, Hercules, CA), using a plasmid-cloned 16S rDNA insert and the
following thermal profile: 95°C for 3 minutes, followed by 40 cycles of 95°C for 20
seconds, 66°C for 30 seconds. Sanger sequencing confirmed primer specificity for each
species and primers pair.
For scanning electron microscopy cells from 20 ml of culture were collected onto
a 0.1μm PVDF syringe filter, washed with phosphate buffered saline (PBS, pH 7), fixed
with 3% glutaraldehyde in PBS for 1 hour at room temperature, followed by three 10
minutes wash steps with PBS. Fixed cells were resuspended in 2% osmium tetraoxide in
PBS for 1 hour, collected by centrifugation at 10,000 x g for 5 minutes, and washed three
times in water (10 minutes each). On the final wash, cells were deposited onto a 3X4mm
silicon chip (Ted Palla, Inc, CA) for 15 minutes followed by dehydration in an ethanol
series (50, 70, 95, 100%), 10 minutes each. The cells were dried in a Ladd critical-point
dryer then gold-coated using an SPI sputter coater and examined on a Zeiss Auriga
Focused Ion Beam Scanning Electron Microscope.
Physiological characterization. Optimum pH was determined in Lactate-Baar
medium containing 5% F. nucleatum CFS, and 15mM MES, MOPS, and/or HEPES, with
the pH adjusted between 5 and 8 at 0.5 unit intervals (MES for pH 5-6, MES + MOPS for
pH 6.5, MOPS for pH 7, MOPS + HEPES for pH 7.5, and HEPES for pH 8). Growth was
monitored for one week at 37°C by daily measurements of optical density at 600nm.
Utilization of electron donors was determined in Lactate-Baar medium containing 5% F.
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nucleatum CFS and each substrate at 10mM. Substrates tested include citrate,
propionate, acetate, lactate, formate, fumarate, succinate, malate, pyruvate (all as sodium
salts), glucose, fructose, ethanol, and propanol. Hydrogen utilization was determined in
the presence of sodium acetate and H2/CO2 (80/20, v/v). Utilization of electron acceptors
was determined with sodium lactate (10mM) in minimal sulfate-free medium (L-1 distilled
water): 2g MgCl2, 1g NH4Cl, 1g yeast extract, 10mM MOPS, 10mM HEPES, 3 mM
K2HPO4, 2.5mM cysteine, 0.5 mg resazurin and 5% F. nucleatum CFS and containing
20mM sodium sulfate, sulfite, thiosulfate or nitrate. Fermentative capabilities were
determined in the same basal medium used for the electron acceptor test, however
lacking addition of electron donor-acceptor pairs. Substrates tested for fermentation
include sodium lactate (20mM), sodium pyruvate (20mM), peptone (0.1%), mucin
(0.25%), synthetic amino acids supplements (Y1501, Sigma)(0.2%), or dextrose (0.2%).
F. nucleatum CFS susceptibility to inactivation was tested by treatment (2 hours at
37°C) with proteinase K (0.2 mg/mL) or incubation at 80°C for 14 hours prior to
supplementation into Lactate-Baar medium at 5% v/v. For testing potential replacement
of CFS with defined amino acids, vitamins, and siderophores, yeast synthetic dropout
media (amino acids) were added to 0.2% and ATCC vitamins to 1% in Lactate-Baar media
prior to inoculation. Siderophore mixture contained a 1:1:1 mix of pyoverdines, 2,3dihydroxybenzoic acid, and ferrichrome and were added to a final concentration of
1g/ml. The cultures were monitored by optical density and microscopic examination for
two weeks. Very weak growers were transferred to fresh media and monitored for growth
up to 1 month. Growth was considered positive if an increase in OD 600 occurred after
three consecutive passages. All experiments were performed in triplicate.
To determine metabolic byproducts of lactate respiration and pyruvate
fermentation,

soluble

analytes

were

measured

via

high-performance

liquid

chromatography (HPLC) using a Waters Breeze 2 system (Waters Corp., Milford, MA,
USA) equipped with a refractive index detector (model 2414) and an Aminex HPX-87H
column (Bio-Rad Laboratories). Sulfuric acid (5mM) was used as the mobile phase at a
flow rate of 0.6 mL/min. Peak areas and retention times were compared against known
standards.
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Genomic sequencing and analysis. D. oralis genomic DNA isolated using the
phenol-chloroform method described (164) was used to construct of a large insert (20kb)
library for sequencing on a PacBio RS II system (Institute for Genome Sciences,
University of Maryland School of Medicine). We generated 154,149 reads, with N50
length of 20.2 kbp and median of 14 kbp, which were assembled into one polished contig
2,796,768 bp in length, with 668 mean coverage, using PacBio SMRT Portal. We also
sequenced in-house a small insert D. oralis genomic library on an Illumina MiSeq
platform. Approximately 4 million reads (2x250 nt) were mapped on the PacBio contig
using Geneious v.10. (179). Individual indel discrepancies were resolved based on both
read coverage and inspection of their effect of disruption/truncation of predicted ORFs in
that region. Contig end overlaps were identified which resulted in circularization of the
initial contig into one chromosome of 2,774,417 bp. The finished genome was submitted
to GenBank for gene prediction and annotation using NCBI PGAP (accession number
CP021255) and to JGI IMG (IMG Genome ID 2711768589). In addition to the annotations
provided by the NCBI and IMG platforms, which included Pfam, COG, TIGRFam, KO,
EC, secretion signals and transmembrane domains, we also analyzed the predicted
proteins and their functions through MetaCyc, eggNOG and TransportDB. For metabolic
reconstruction we combined the use of the IMG networks, KEGG-BlastKOALA, and
MetaCyc-Pathway Tools with individual gene searches (blast and hmmsearch), sequence
alignments, and phylogenetic reconstruction using homologues from related sulfate
reducers, acetogens, or human microbiome bacteria. Sequence alignments were
performed using Muscle and maximum likelihood phylogenetic reconstructions were
based on PhyML or FastTree, all implemented in Geneious. Genomic alignments were
displayed using Circos (180).
Pro-inflammatory cytokine secretion assays. Late log cultures of D. oralis
grown under pyruvate fermentation condition (50 mL, three replicates) were chilled on
ice, and spun by centrifugation (4°C 10,000 x g for 10 minutes). The cell pellets were
flash-frozen at -80°C and the spent medium was passed through a 0.22μm Millipore filter
and frozen at -20°C.
Immortalized human oral keratinocytes (OKF6/TERT-2) were grown on
keratinocyte-SFM 1X medium (Invitrogen, Carlsbad, CA) supplemented with epidermal
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growth factor (0.3 ng/mL), bovine pituitary extract (50 μg/mL), 1 IU/mL penicillin and 1
μg/mL streptomycin to reach ~50% confluence, in 12-well tissue culture plates (Corning
Inc., Corning, NY, USA) pre-coated with 3 mg/mL collagen (Stemcell Technologies,
Vancouver, Canada). To each well we added 100l of (a) D. oralis filtered spent medium
(100l), (b) D. oralis cells re-suspended in keratinocyte medium, (c) fresh D. oralis
medium, or (d) fresh keratinocyte medium (negative controls), each in triplicate for every
triplicate D. oralis biological sample. Keratinocytes were incubated for 48 hours at 37°C,
after which media samples were collected, clarified by centrifugation, and frozen in
aliquots at -20°C. Cytokine concentrations were measured with the LEGENDplexTM
human inflammation panel (13-plex)(BioLegend®, San Diego CA, USA) following
manufacturer’s instructions, using a Cytopeia Influx flow cytometer (BD, Franklin Lakes,
NJ, USA). Statistical analysis was performed using GRAPHPAD PRISM Version 7. Oneway analysis of variance (ANOVA nonparametric) with Tukey correction was used to
investigate significant differences between independent groups of data. Statistical
differences were considered significant at p <0.05.
Whole cell and secreted proteome data acquisition. Samples from the same
three replicate D. oralis cultures used for the pro-inflammatory assay were also used for
proteomic analysis, conducted as detailed in (181). Cell pellets were resuspended in 4%
sodium deoxycholate (SDC) in 100 mM ammonium bicarbonate (ABC) and ultrasonically
disrupted. The crude protein extract was clarified by centrifugation, reduced with 10 mM
dithiothreitol (DTT), and cysteine residues blocked with 30 mM iodoacetamide (IAA). The
proteins were then collected on top of a 10 kDa cutoff spin column filter. D. oralis spent
culture medium samples (~12 mL) were concentrated on a 5 kDa filter. Collected proteins
were washed with ABC and digested with sequencing-grade trypsin (Sigma). Peptides
were collected by centrifugation, acidified to 1% formic acid (FA) followed by extraction
with ethyl acetate and concentrated. The peptide mixture was analyzed by automated,
two-dimensional liquid chromatography tandem mass spectrometry (2D-LC-MS/MS)
system (181) using Ultimate 3000 RS system in-line with Q Exactive Plus (QE+) mass
spectrometer (ThermoFisher Scientific).
Proteomic analyses. All MS/MS spectra were searched against a constructed
FASTA database containing all proteins predicted from the sequenced genome of
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Desulfobulbus oralis, concatenated with common contaminants and reversed-decoy
sequences using Myrimatch version 2.2 (182). Peptides were identified and proteins
inferred using IDPicker version 3.1 (183) with an experimental false discovery rate (FDR)
<1% at the peptide level. Peptide abundances were derived in IDPicker by extracting
precursor intensities/area-under-the-curve from chromatograms with the following
parameters: retention time of ±90 s and mass tolerance of ±5 ppm. Protein abundances
were calculated by summing together intensities of all identified peptides and normalized
by their respective protein lengths. Protein abundances were log2-transformed and
median-centered across all samples in InfernoRDN version 1.1 (184).
To investigate enriched secreted proteins, we performed Student’s t-tests between
the cell pellet and the spent medium (supernatant) samples using Perseus software
platform (185). We limited the comparison to those proteins observed in all supernatant
experiments to better focus on proteins that could be secreted and/or induce inflammatory
response. Proteins with missing values were imputed from a normal distribution (width =
0.3, shift = 1.8). A protein was considered as significantly enriched in the supernatant if it
passed the threshold of Benjamini-Hochberg FDR < 0.01 and log2 fold-change greater
than 2 in the comparison of supernatant versus cell pellet.
Metatranscriptomic data analysis. MiSeq data for 10 healthy subjects and 6 with
periodontitis

(178)

was

downloaded

from

MG-RAST

(http://metagenomics.anl.gov/linkin.cgi?project=5148). The reads were mapped to the D.
oralis genome with bowtie2 v. 2.2.6 (with parameters: --very-sensitive-local --no-unal -X
1000 --score-min G,20,28 --no-mixed --rg-id). The resulting sam files were converted and
sorted with samtools 0.1.19, alignments were inspected with IGV 2.3.55, and mapping
was

quantitated

with

htseq-count

v.

0.6.1p1.

Code

used

is

available

at

https://github.com/cliffbeall/Doralis-metatrans.
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Table A2.1. D. oralis physiological characteristics compared to related species of the
Desulfobulbus genus.
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Figure S1. Phylogenetic analysis (FastTree) of selected horizontally-aquired genes in D. oralis.
Closest sequence homologues from other bacteria (based on Blast) were used. For most genes
proposed to have been horizontally aquired there were no close homologues in other Desulfobulbus
genomes. The numbers indicate node support.
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Figure A2.1. Phylogenetic analysis (FastTree) of selected horizontally-acquired genes in
D. oralis. Closest sequence homologues from other bacteria (based on Blast) were used.
For most genes proposed to have been horizontally acquired there were no close
homologues in other Desulfobulbus genomes. The numbers indicate node support.
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Figure A2.1. (continued)
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Figure A2.1. (continued)
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Figure A2.2. Cytokine stimulation in oral epithelial keratinocytes by Desulfobulbus oralis
supernatant. Keratinocytes were incubated with D. oralis supernatant for 48h and
cytokine stimulation was measured using Biolegend LEGENDplex multiplex beads. Each
bar represents  standard deviation of the mean of triplicate measurements of mean
technical duplicates. Significantly different from D. oralis medium-only control under
fermentative conditions (lacking sulfate): * p < 0.05, ** p < 0.01. IL, interleukin; IFN,
interferon.
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Supplementary Figure 2 | Cytokine stimulation in oral epithelial
keratinocytes by Desulfobulbus oralis supernatant. Keratinocytes were
incubated with D. oralis supernatant for 48h and cytokine stimulation
was measured using Biolegend LEGENDplex multiplex beads. Each bar
represents ± standard deviation of the mean of triplicate measurements
of mean technical duplicates. Significantly di fferent from D. oralis
medium-only control under fermentative conditions (lacking sulfate):
* p < 0.05; ** p < 0.01. IL, interleukin; IFN, interferon.

53

Figure A2.3. Cytokine stimulation in oral epithelial keratinocytes by Desulfobulbus oralis
cells. Keratinocytes were incubated with D. oralis supernatant for 48h and cytokine
stimulation was measured using Biolegend LEGENDplex multiplex beads. Each bar
represents  standard deviation of the mean of triplicate measurements of mean technical
duplicates. Significantly different from keratinocyte medium-only control: * p < 0.05, ** p
< 0.01. IL, interleukin; IFN, interferon.
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Supplementary Figure 3. Cytokine stimulation in oral epithelial
keratinocytes by Desulfobulbus oralis cells. Keratinocytes were incubated
with D. oralis cells for 48h and cytokine stimulation was measured using
Biolegend LEGENDplex multiplex beads. Each bar represents ± standard
deviation of the mean of triplicate measurements of mean technical duplicates.
Signifcantly different from keratinocyte medium-only control: * p < 0.05;
** p < 0.01. IL, interleukin; IFN, interferon.
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CHAPTER THREE - A step towards elucidating the growth promoting
characteristics of Fusobacterium nucleatum for cultivation of oral
bacteria
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Abstract
Periodontitis is the leading cause of tooth loss worldwide. Moreover, it has a
complex etiology originating from within the human oral microbiome. Some of the
periodontal pathobionts have been identified but many disease-associated lineages
remain uncultured, in part due to not yet understanding what these microorganisms may
require for growth in the laboratory. Cultivation is important because it provides the
opportunity to test specific hypotheses that can tease apart correlation vs. causation in
disease studies.

Some oral microorganism have been shown to be dependent on

Fusobacterium nucleatum for growth (39-41, 121). However, it remains unknown what
molecules produced by F. nucleatum stimulate the growth of other oral species. Using
the culture system between the recently isolated Desulfobulbus oralis and F. nucleatum,
we began to investigate what results in the strict requirement of D. oralis for F. nucleatum
by-products for growth in pure culture to occur. Understanding the relationship between
D. oralis and F. nucleatum and what D. oralis may require from F. nucleatum for growth
could allow for the cultivation of more disease-associated bacterial lineages. Using
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metabolomics, we began to elucidate the metabolic by-products of F. nucleatum growth
as a step towards uncovering the growth requirements of D. oralis.

Background
Within the human oral cavity, great strides have been made in culturing the diverse
array of microorganisms present there. The human oral cavity is home to over 770
species-level taxa (14) and has evolved to exist in complex biofilms/communities that
have resulted in genome reduction and strict interspecies interactions (50). As a result,
many bacteria remain recalcitrant to cultivation until such dependencies can be identified.
We recently cultured the first oral Desulfobulbus, D. oralis, and showed a dependency of
D. oralis on F. nucleatum for growth in pure culture to be maintained (186). Although this
interaction has been seen before (39-41), it still remains unknown what is produced by F.
nucleatum that stimulates the growth of other oral species. Understanding the relationship
between D. oralis and F. nucleatum and what D. oralis may require from F. nucleatum for
growth could allow for the cultivation of more bacteria and disease-associated bacterial
lineages. Additionally, understanding how such species interactions have developed can
shed light on how host microbiomes have evolved.
We used the D. oralis-F. nucleatum culture system to begin to investigate the
metabolic by-products of F. nucleatum growth to try and determine the basis of this
dependency. We began by optimizing a chemically defined medium (CDM) that supports
the growth of F. nucleatum and determined that this medium alone could not support
growth of D. oralis. We then sought to identify the metabolic by-products of F. nucleatum
and further fractionated the resulting supernatant for further analysis via mass
spectrometry. We tested the effect of these individual fractions on D. oralis growth and
began to build hypotheses about what may result in the inability of D. oralis to grow in the
absence of F. nucleatum.

Results and Discussion
Optimization of a chemically defined medium for growth of Fusobacterium
nucleatum. Desulfobulbus oralis was originally isolated along with a co-isolated strain of
Fusobacterium nucleatum animalis (186). A cell-free-supernatant (CFS) following F.
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nucleatum growth also supports growth of D. oralis in lab media. Further characterization
identified that F. nucleatum nucleatum ATCC 25586 also supported growth of D. oralis
and was therefore used for the purpose of these tests as it is a well characterized, wholegenome-sequenced reference strain of F. nucleatum. Standard growth conditions for F.
nucleatum involve rich media (e.g. ATCC 1490, modified chopped meat medium).
However, the very high chemical complexity of such media makes it difficult to identify the
compounds F. nucleatum secretes as a result of its metabolism. Therefore, we selected
a chemically defined medium (CDM), previously reported for the growth of oral bacteria
(187, 188). F. nucleatum grows in that medium under continuous culture conditions (189,
190). To improve the growth in batch cultures we made some modifications: decreasing
the levels of reducing agents and buffers and selecting glucose instead of amino acids
as the primary energy source. The final CDM included amino acids, nucleotides, and
vitamins (Table 3.1) and supported F. nucleatum growth similar to rich media.
Fusobacterium grown in chemically defined medium supports the growth of
Desulfobulbus oralis. Although F. nucleatum in CDM paralleled that in complex media,
it was unknown if in the CDM F. nucleatum produced the metabolite(s) required by D.
oralis. We tested samples from a batch culture of F. nucleatum over 70 hours of growth,
spanning the various growth stages (lag, early and late exponential and stationary
phases) (Figure 3.1). Cell-free-supernatants (CFS) prepared (as detailed in (186)) from
those samples were supplemented (10% v/v) into D. oralis cultures and growth was
measured by OD600 (Figure 3.2). D. oralis growth was induced by F. nucleatum CFS from
early culture stages (6 hours) and peaked around 27 hours when exponential phase was
reached. The CDM itself did not support the growth of D. oralis suggesting that F.
nucleatum secretes a metabolite distinct from the standard amino acids, nucleotides or
vitamins present in the medium.
Metabolomics analysis of Fusobacterium cell-free-supernatant by GC-MS.
Passing all CFS through a 3kD filter did not remove its growth promoting characteristic,
suggesting that compound(s) required by D. oralis is not a macromolecule. To begin
characterizing the small molecule metabolites produced by F. nucleatum we analyzed
CFS from mid-log cultures (OD600 = 0.46) by gas chromatography mass spectrometry
(GC-MS). Using CDM as a control, we compared the chromatogram profiles aiming to
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Table 3.1. Composition of the chemically defined medium (CDM).
Components

Concentration Amino Acids

Concentration

Glucose

15mM

Glutamic acid

2mM

NaCl

200M

Histidine

2mM

CaCl-2H20

150M

Lysine

2mM

MnSO4

60M

Leucine

8.75mM

MgSO4

1.66mM

Alanine

2.55mM

NaCitrate

1mM

Arginine

1.31mM

FeSO4

66M

Asparagine

1.72mM

Na2MoO4

700nM

Aspartic Acid

1.72mM

K2HPO4

5mM

Cysteine

1.88mM

Na2HPO4

5mM

Glutamine

1.56mM

K2CO3

8mM

Glycine

3mM

(NH4)2SO4

4.5mM

Myo-inositol

1.26mM

Isoleucine

1.74mM

Concentration

Methionine

1.53mM

Folic acid

250nM

Phenylalanine

1.38mM

Pyridoxine hydrochloride

2.5M

Proline

2mM

Riboflavin

650nM

Serine

2.17mM

Biotin

500nM

Threonine

1.9mM

Thiamine

959nM

Tryptophan

1.1mM

Nicotinic acid

2M

Tyrosine

1.26mM

Calcium Pantothenate

500M

Valine

1.95mM

Vitamin B12

1nM

Nucleotides

p-Aminobenzoid acid

4M

Guanine

175M

Thioctic acid

1M

Uracil

275M

Adenine

400M

Vitamins

Concentration

60

0.9

= timepoints for filtrates

0.8

46h

OD600

0.7

27h

0.6

0.5

Time

0.4

0h

OD600 0.000

6h
0.032

21h
0.267

27h

46h

0.531

0.760
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0.3
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Figure 3.1. Growth of Fusobacterium nucleatum on chemically defined medium (CDM).
Red diamonds indicate points of growth where cell-free-supernatant (CFS) was collected
and tested in Figure 3.2. Inset table shows the OD600 of the culture at the time of
collection.
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Figure 3.2. Growth of Desulfobulbus oralis after supplementation with CFS collected at
times 0, 6, 21, 27, and 46 hours of F. nucleatum growth. Growth curve is representative
of duplicate tests.
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identify peaks (metabolites) unique to the CFS. The results from GC-MS detected the
presence of cadaverine, cystine, 2-hydoxybutyric acid, and 2-hydroxyglutaric acid
(Figure 3.3) as well as three unknowns not present in the CDM. Based on these findings,
we tested pure 3-indolebutyric acid, gamma-aminobutyric acid (GABA), cystine, 2hydoxybutyric acid, 2-hydroxyglutaric acid, 2-ketoglutaric acid, and 2-ketobutyric acid for
growth support of D. oralis. A mixture, as well as individual compounds, were added to
D. oralis cultures at varying concentrations to determine whether they could stimulate
growth. None of the amendments led to D. oralis growth.
Chemical fractionation of F. nucleatum CFS. To reduce the complexity of the
CFS we applied organic phase extraction by using ethyl-acetate and methanol solvent
extractions. A total of 14 fractions were collected and tested as to whether or not they
supported D. oralis growth (Figure 3.4). The ethyl-acetate extractions showed the biggest
degree of variability between the samples with fraction 2 (EtAc2) stimulating growth to
native growth densities (Figure 3.4a). Fractions 3 and 4 (EtAc3 and EtAc4) showed the
most similar growth stimulation to that of the positive control while EtAc1 was most
comparable to the negative control sample suggesting growth stimulation did not occur in
that fraction. The alkaline and acidic methanol extractions showed less variability when
compared to each other (Figure 3.4c,d) with all fractions supporting growth to varying
degrees. As we wanted to target a distinct fraction that supported growth relative to the
others, we focused on ethyl-acetate fraction 2 (EtAc2). We analyzed fraction EtAc2 via
GC-MS and identified a single pronounced peak for 2-hydroxybutyric acid.
Ongoing experiments are testing pure 2-hydroxybutyric acid in combinations with
amino acids and vitamins to determine whether this compound is capable of stimulating
D. oralis growth in the absence of F. nucleatum. Additionally, as GC-MS may miss some
compounds, we are analyzing EtAc2 via liquid chromatography mass spectrometry (LCMS) and nuclear magnetic resonance (NMR).

Conclusions
The recent cultivation of Desulfobulbus oralis provides a novel platform with which
to further understand how such organisms have evolved and became dependent on other
microorganisms for growth. Understanding how microorganisms have evolved with each
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2-hydroxybutyric acid

CFS

CFS

Medium-only

Medium-only

2-hydroxyglutaric acid

Figure 3.3. Example extracted ion chromatograms from GC-MS for the presence of 2hydroxybutyric acid (left) and 2-hydroxyglutaric acid (right) in CFS after the growth of F.
nucleatum.
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Figure 3.4. Growth of D. oralis on the various CFS extractions. a. Ethyl-acetate (EtAc)
extractions 1-4 (see methods) as compared to a CFS dehydrated positive control (supe
+) and a no additions negative control (minus additions). b. Alkaline methanol (Alk)
extractions for flow-through (FT), wash 5% (W5), 20%, 40%, and 80% methanol as
compared to a no additions negative control. c. Acidic methanol (Ac) extractions for flowthrough (FT), wash 5% (W5), 20%, 40%, and 80% methanol as compared to a no
additions negative control.
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other, and with the human host, will provide insights into what results in microbial
“unculturability”. As periodontal disease is a result of a community shift favoring specific
microorganisms, understanding these microbe-microbe interactions can shed light on
what may trigger a dysbiotic environment. Here we made strides in understanding the
metabolic signature of Fusobacterium nucleatum and what may result in the stimulation
of other oral bacteria.

Materials and Methods
Microbial Cultivation. Pure cultures of D. oralis were grown in a modified LactateBaar medium containing (L-1 distilled water): 2g MgSO4.7H2O, 1g (NH4)2SO4, 10mM
MOPS, 10mM HEPES, 10mM sodium lactate, 0.1% yeast extract, 2.5mM cysteine, and
0.5 mg resazurin 0.5%. The pH of the media was adjusted to 7-7.1 with 8M NaOH,
degassed with N2 (100%) and autoclaved for 30 minutes at 121°C in balch tubes fitted
with butyl rubber stoppers. After cooling, sterile K2HPO4 (0.5M, pH 7) was added to 3mM
final. F. nucleatum was grown in either BHI autoclaved or CDM (Table 3.1) (amino acids
and vitamins were prepared using synthetic amino acids supplements (Y1501, Sigma)
and a vitamin mix (ATCC MD-VS)) pH 7.3. filter-sterilized with 0.22μm NalgeneTM
Rapid-FlowTM sterile filters, both under 85%N2, 10%CO2, 5%H2. F. nucleatum cell-freespent supernatant (CFS) was prepared by filtering cultures through two 0.22μm
NalgeneTM Rapid-FlowTM sterile filters and degassing with N2 (100%) and 1mM cysteine
was added to keep it reduced in balch tubes fitted with butyl rubber stoppers and added
to D. oralis medium 10% v/v. Culture stocks were preserved by freezing at -80°C after
adding DMSO to 10% (v/v). All OD600 results were measured with either an Eppendorf
BioPhotometer or a Milton Roy Spectronic 21D fit for balch tubes.
Physiological analyses. Preliminary metabolite tests were performed with Lalpha-hydroxyglutaric acid disodium salt, 2-hydroxybutyric acid sodium salt (97%), Lcystine dihydrochloric acid, indole-3-butyric acid, 2 ketobutyric acid, 2 ketoglutaric acid,
and gamma-aminobutyric acid (Sigma-Aldrich). Hydroxybutyric acid, hydroxyglutaric
acid, ketobutyric acid, and ketoglutaric acid were prepared at 100mM in water. Indole-3butyric acid was prepared at 100mM in 100% ethanol. Cystine (100mM) was prepared in

66

1M HCl. Additions were filter-sterilized, degassed with N2, and added to D. oralis medium
at 1-2mM, 0.1-0.2mM, and 0.001-0.002mM and pH was controlled by MOPs.
Ethyl-acetate extractions were prepared by adding F. nucleatum CFS (neutral pH)
to ethyl-acetate (EtAc) and mixing vigorously. Samples were spun at 2000 x g for 2
minutes to facilitate separation. Top fraction was recovered (EtAc1). Remaining aqueous
solution was acidified with HCl to pH 4.5 and EtAc was added to this and mixing and
spinning was repeated. Top fraction was recovered (EtAc2) and bottom phase (EtAc3).
Remaining aqueous phase was acidified to pH 2.3 and further extracted with EtAc by
mixing and spinning as above (EtAc4). Solvent was removed from samples using a speed
vac and either directly prepared for mass spectrometry or resuspended in CDM and
brought to neutral pH, filter-sterilized, degassed with N2, and added to D. oralis medium
at 10% v/v.
Methanol extractions were prepared by using a Sep-Pak C18 plus short cartridge
(360mg Sorbent per Cartridge) product #WAT02515. F. nucleatum supernatant was split
into two equal portions, one was acidified with HCl to pH 2.2 and the other was made
alkaline with KOH to pH 10. Each was then processed for fractions. Solutions of methanol
were prepared: 5%, 20%, 40%, 80% in molecular grade water solutions. Using 10ml
syringes, the columns were first slowly washed with 100% methanol to remove impurities
and to wet the column. Then the columns were equilibrated with a 5% methanol solution.
Sample was then slowly passed through the filter and collected (Ac or Alk flow-through
or FT). Then, another 5% methanol wash was passed through the filter and collected (Ac
or Alk wash 5% or W5). Then the different percentages of methanol were used to elute
(20->40->80 Ac or Alk 20/40/80"). Solvent was removed from samples using a speed
vac and either directly prepared for mass spectrometry or resuspended in CDM and
brought to neutral pH, filter-sterilized, degassed with N2, and added to D. oralis medium
at 10% v/v.
Cellular and molecular analyses. To monitor cultures, 16S rRNA gene
sequencing was used throughout to confirm purity of the cultures. DNA was extracted
using a Zymogen Research fungal/bacterial DNA MiniPrep kit and PCR-amplification was
carried out using the universal primer set 27F (5’-AGAGTTTGATYMTGGCTCAG-3’) and
1492R

(5’-TACGGYTACCTTGTTACGACTT-3’).

Amplification

with

EconoTaq
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(Lucigen©) used the following thermal profile: 95°C for 3 minutes, followed by 32 cycles
of 95°C for 30 seconds, 56°C for 45 seconds, 72°C for 90 seconds, and a final extension
of 72°C for 5 minutes. Single band products were directly sequenced at Eurofins
Genomics (Louisville, KY, USA) using Sanger chemistry.
GC-MS analyses. For GC-MS, 15 µL of sorbitol (1 mg/mL) was added as an
internal standard to a 50 µL aliquot of sample and then dried under a stream of nitrogen.
Following evaporation, trimethylsilyl derivatives were generated by dissolving the dried
sample residue in 0.5 mL of silylation–grade acetonitrile followed by addition of 0.5 mL of
N-methyl-N-trimethylsilyltrifluoroacetamide

with

1%

trimethylchlorosilane

(Thermo

Scientific, Bellefonte, PA) and heating for 1 hour. A 1 µL aliquot of the trimethylsilyl
derivatives solution was injected into an Agilent Technologies Inc. (Santa Clara, CA)
5975C inert XL gas chromatograph-mass spectrometer (GC-MS) fitted with an Rtx-5MS
with Integra-guard (5% diphenyl/95% dimethyl polysiloxane) 30 m x 250 µm x 0.25 µm
film thickness capillary column. The quadrupole GC-MS was operated in the electron
ionization (70 eV) mode with 6 full-spectrum (50–650 Da) scans per second; gas (helium)
flow was set at 1 mL/min with the injection port configured in the splitless mode. The
injection port, MS source, and MS quad temperatures were set to 250 °C, 230 °C, and
150 °C, respectively. The initial oven temperature was held at 50 °C for 2 min and was
programmed to increase at 20 °C per min to 325 °C, to hold for 11 min, and then to return
to the initial 50 °C hold. Peaks were assigned using a custom mass spectral database,
the Wiley Registry 8th Edition mass spectral database and the NIST 05 mass spectral
database.

68

CHAPTER FOUR - Targeted isolation and cultivation of microbial
“dark matter” through reverse genomics
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Abstract
The vast majority of microorganisms, across all taxonomic levels, have remained
uncultured. Single cell genomes and metagenomes are expanding the known diversity of
Bacteria and Archaea and have facilitated inferences of potential physiological and
environmental roles, but most are not experimentally validated. Ideally, sequence data
should enable targeted microbial isolation, cultivation, and characterization. Here we used
genome-informed antibody engineering to selectively isolate single cells, cultivate
previously “unculturable” bacteria, and identify novel symbioses. By targeting the
candidate phylum TM7 (“Saccharibacteria”) from the human oral microbiota, we
sequenced genomes representing 8 distinct lineages. Viable cell isolation enabled
cultivation of three different species-level lineages of oral TM7 as epibionts on diverse
Actinobacteria, demonstrating that this approach can lead to discovery and
characterization of novel interspecies partnerships. As the concept could be applied to
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any group of microorganisms, from any environment, it unlocks the potential to directly
isolate, culture, and characterize representatives of the yet-uncultured branches of the
microbial tree of life.

Introduction
Our understanding of the microbial tree of life has undergone continuous reshaping
and refinement ever since the introduction of molecular, culture-independent methods to
identify and classify organisms. While pre-genomic, ribosomal RNA gene sequencing
resulted in the discovery of nearly two dozen candidate Bacteria and Archaea phyla (191),
more recent single-cell genomic and metagenomic assemblies (SAGs and MAGs) have
led to a deluge of proposed novel lineages (27, 192-194). Notably, however, SAGs and
MAGs of specific, target taxa are generally retrieved by chance, depending on their
abundance in the community and currently there are no effective ways to focus on
specific, individual taxa. Furthermore, although microbial cultivation has been successful
for representatives of a handful of phyla initially discovered by rRNA sequencing, the vast
majority of candidate microbial taxa remain uncultured. Genome-based metabolic
reconstructions can provide important insights into the lifestyle and characteristics of
various uncultured Bacteria and Archaea but, with few exceptions, have not led to
targeted isolation of novel microbes (164, 195). Growth requirements of many organisms
may be too complex, or too subtle, for genomic-based predictions and may depend on
specific

interspecies

interactions

TM7/”Saccharibacteria” (45)).

(e.g.

Nanoarchaeota

(164,

196,

197),

High-throughput cultivation approaches, multispecies

consortia, and addition of various growth factors have been used successfully to
propagate and isolate “unculturable” organisms from various environments including
soils, water, sediments, and the human microbiome (41, 198-202). However, being able
to directly link the genotype to actual cells while maintaining cellular viability would enable
isolation of cells from target microbial taxa for selective genomic sequencing or cultivation
and characterization of interspecies interactions. Here we introduce such an approach,
using antibodies against predicted cell surface protein epitopes from uncultured bacteria,
with human oral TM7/"Saccharibacteria” as a test case (Figure 4.1a).
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Figure 4.1. Overview of targeted microbial isolation through reverse genomics. a.
Diagram showing the steps in reverse genomics-enabled microbiology: (1) Identification
of membrane protein-encoding genes in SAGs and MAGs, (2) selection of predicted
exposed epitopes, (3) antibody production, (4) purification and fluorescent labelling, (5)
staining of target cells from microbiome samples (6) and isolation for genomic sequencing
(7) or cultivation (8). b. X-ray structure of penicillin-binding protein from E. coli, with the
modeled TM7 glycosyltransferase (GT) domain colored blue and the selected epitope
region highlighted in yellow-brown. c. Structural model of TM7a capsular polysaccharide
biosynthesis protein (cpsC), with the peptide epitope region in purple.
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TM7 was one of the first candidate bacterial phyla proposed two decades ago
based on rRNA gene sequences (76, 203) and was subsequently detected in a wide
range of environments, including in association with plants and animals. Following
metagenomics-based genomic assembly of near-complete genomes for several TM7
lineages from activated sludge, the group has been renamed “Saccharibacteria” (44)
(204), although as a formal classification and valid description are still lacking. In humans
approximately a dozen distinct species-level TM7 are recognized (205), mostly in the oral
cavity, and their increased abundance has been correlated with the development of
periodontitis (206) and inflammatory bowel disease (74). Related lineages have also been
identified in dogs, cats and dolphins (127, 207, 208). The first genomic data for a human
oral TM7 was generated by single-cell sequencing following micro-isolation from
supragingival plaque (28). Recently, the first TM7 bacterium (TM7x) was cultured as an
obligate epibiont on the human oral Actinomyces odontolyticus, based on serendipitous
streptomycin resistance (45). Considering the large taxonomic diversity and ubiquitous
environmental presence of these organisms, generally at low abundance (<1%), we
selected TM7 for developing reverse genomics-enabled microbial isolation.

Results
Selection of TM7 bacterial cell surface antibody targets. We used the first
single-cell genomic data from a human oral TM7 (TM7a)(28) to identify genes encoding
predicted membrane-associated proteins for which function could be inferred, based on
homologues from other bacteria. We avoided hypothetical proteins, because in the
absence of gene expression information we considered those less likely to be present on
the cell surface. It should be noted, however, that if experimental data (e.g. based on
metaproteomics, metatranscriptomics) would be available, any categories of membrane
protein could be a potential target. We then screened for proteins with extracellular
domains that could be used as antigens for antibody development and which had
homologues with solved three-dimensional structures. A candidate protein that satisfied
these criteria was a predicted penicillin-binding protein (PBP2). In pathogenic bacteria,
PBP2 has been shown to be an effective vaccine target, indicating that the protein is
expressed and can be recognized by an antibody (209). Crystal structures for
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Staphylococcus aureus (PDB entry 3DWK) and Escherichia coli (3VMA) protein
homologs were used to model the TM7a PBP2 and identify potentially exposed epitopes.
PBP2 is anchored in the membrane by a single -helix and consists of two extracellular
domains, an N-terminal glycosyltransferase (GT) domain and a C-terminal transpeptidase
(TP) domain connected by a -rich linker region (210) (Figure 4.1b). A 19-amino acid
sequence located in the GT domain was selected as antigen based on surface exposure,
predicted immunogenicity and solubility, and was used for raising polyclonal antibodies
(Figure A4.1) (all additional material occurs in the chapter appendix). As experimental
structure data for membrane proteins is relatively scarce, computational prediction may
also be used for antigen selection. Capsular polysaccharide biosynthesis protein (CpsC)
was selected as second target but it lacked close homologues with solved structures. We
generated a Rosetta 3D structure model using coevolution-derived residue-residue
contact restraints (211), and a predicted antigenic peptide from an extracellular -helical
domain was used to raise antibodies.
While for this study we selected short peptides, entire protein domains could be
used as antigens for generating polyclonal antibodies. Such antibodies would target
multiple regions of the membrane protein and could increase the chance of binding,
especially if some residues may be sterically hindered (e.g. due to glycosylation).
However, depending on the degree of sequence conservation, antibodies raised against
protein domains may be less specific and bind to bacteria other than the target group.
Antibody-enabled isolation and cultivation of oral TM7/Saccharibacteria
symbiotic lineages. Human oral samples (saliva, subgingival fluid) from orally healthy
donors and from patients with periodontitis were incubated with fluorescently labeled antiPBP2 and anti-CpsC IgGs (anti-TM7). Stained samples were analyzed by flow cytometry,
revealing a distinct population of fluorescent cells (0.1-5%, depending on the sample)
(Figure 4.2a, b). To determine if Saccharibacteria were labeled by the antibody, we
sorted pools of 10-100 fluorescent cells followed by multiple displacement genomic
amplification (MDA). We then assayed for the presence of TM7 bacteria using PCR with
specific primers targeting the small subunit ribosomal RNA (SSU rRNA) gene followed by
Sanger sequencing or by MiSeq amplicon sequencing of the V4 region of the SSU rRNA
gene amplified with universal primers. Between 25-100% of the cell pools were positive
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Figure 4.2. Isolation of TM7 cells by flow cytometry cell sorting. a-b. Flow cytometry plot
(forward scatter “FSC” versus green fluorescence “RFU”) of native (a) and TM7 antibodylabelled oral samples (b). The sort gate area indicates selection characteristics for cell
sorting.

Highly

fluorescent

particles

(RFU>103)

are

auto

fluorescent

precipitates/minerals. c. Microbial diversity in pools of 10 sorted cell pools, following MDA
and 16S rRNA gene amplicon sequencing. Also shown for comparison is the diversity of
the original subgingival samples (far right column). d. Maximum likelihood tree of human
oral TM7 SSU rRNA sequences, indicating phylotypes retrieved by antibody labeling and
cell sorting (blue dots) and TM7 groups (G1-G6). Circles at nodes indicate bootstrap
values (not shown if <50, black>80). Scale bar = substitutions per site.
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for TM7, depending on individual subjects/samples and gating parameters, with both antiPBP2 and anti-CpsC successfully retrieving TM7 cells. To enhance the fluorescence
signal through dual labelling and to cover as much as possible of sequence variation
space, most experiments were subsequently performed with a mix of the two antibodies.
As

such,

when

we

analyzed

the

pools

for

taxonomic

representation,

Saccharibacteria/TM7 comprised up to 95% of the sequences and represented
phylotypes from groups 1, 3 and 6 (Figure 4.2c, d and Figure A4.2). Other bacteria were
primarily members of Fusobacteria, Actinobacteria, Bacteroidetes, Haemophilus and
Streptococcus. The identification of species other than the target TM7 bacteria may
indicate cross-reactivity of the antibodies, free genomic DNA, and interspecies cellular
adhesion (specific or non-specific) which is extensive in the microbiota (212).
We demonstrated that the anti-TM7 peptide antibodies can label target cells in
biological samples and enable their isolation by flow cytometry. We tested if cell isolation
could then be viable and propagate in cultures. Importantly, such cultures would enable
identification of potential physiological interactions between various TM7 lineages and
other bacteria in the oral microbiota. Using freshly collected oral samples, we labeled the
bacteria with the anti-TM7 antibodies and sorted individual fluorescent particles (cells) on
culture media. Following incubation under anaerobic or hypoxic conditions, the cultures
were tested for the presence of TM7 bacteria using rRNA gene amplicon sequencing.
On solid media, we identified colonies containing five distinct TM7 phylotypes
(species to family/order taxonomic range), HOTs 346, 348, 352, 952/TM7x (all group 1)
and HOT 351 (group 3) (Figure 4.3, Figure A4.3). Based on amplicon sequencing, most
TM7 positive colonies also contained species of Actinobacteria and some also contained
Streptococcus. This finding suggested that Actinobacteria may be host organisms, as
with TM7x, and that Streptococcus cells, known to be highly adherent (213), are coisolates. Surprisingly, TM7 HOTs 346 and 348 (distinct species, based on 93% rRNA
identity), were identified in the same colony with Cellulosimicrobium cellulans, an
actinobacterium present in healthy saliva but occasionally associated with bacteremia
and other diseases (214). As the fluorescent particle could not have contained multiple
Cellulosimicrobium cells that independently also harbored different TM7, multiple epibiont
TM7 species may simultaneously parasitize the same host cell. A second round of
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Figure 4.3. Diversity of cultivated and uncultivated TM7 bacteria. a. Maximum-likelihood
phylogenies of TM7 bacteria and of selected human oral Actinobacteria, based on small
subunit rRNA genes. TM7 bacteria include human oral phylotypes (HOTs) as well as
related host-associated lineages from open environments, identified by sequence
accession numbers and associated with six operational groupings (G1-6). HOTs detected
using antibodies, isolated as single cells, or identified in cultures are indicated by colored
stars. Circles at nodes indicate bootstrap support (>80% filled, 50-80% open, only shown
for major groupings). Lines connecting TM7 and Actinobacteria species indicate epibionthost systems identified previously (blue highlight) and in this study (green). b.
Epifluorescence microscopy images of novel TM7-host associations identified in this
study using immunolabeling (TM7 HOT351-Actinomyces HOT897 and TM7 HOT346Cellulosimicrobium cellulans) or FISH (TM7352-Actinomyces odontolyticus strain OR).
Arrows point to some of the green fluorescent TM7 cocci. Scale bar is 5 m).
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labeling and cell sorting resulted in a pure co-culture of C. cellulans-TM7 HOT346. In a
separate experiment using an oral sample from the same donor, a second TM7 HOT346
strain was co-isolated with Actinomyces sp. HOT171. This represents the first
demonstration that in their natural environment (oral microbiota) a TM7 species can be
an epibiont on bacteria that belong to distinct genera.
TM7 HOT351 is the first cultivated member of a novel family to order-level
TM7/Saccharibacteria taxon (85% 16S RNA identity to TM7x) and was identified in pure
co-culture with a previously uncultured Actinomyces species (A. sp. HOT897), most
closely related to A. dentalis (92% identity). As characterization of all human oral bacteria
has been a continuous effort over decades, the isolation of a novel species of
Actinobacteria further highlights the importance of novel approaches in enabling cocultivation of interacting organisms that were refractory to traditional methods.
For two closely related phylotypes, TM7 HOT352 and HOT952, which belong to
the same species complex as TM7x, we identified the host as Actinomyces odontolyticus
XH001, the known host of TM7x (45). In liquid microcultures we also detected TM7
HOT347 (Group 1) and HOT870 (Group 6) however those cultures could not be
maintained, and we did not identify the native host of those Saccharibacteria lineages.
Identification of multiple oral TM7-host pairs provides the first substantial view into the
evolution of such interbacterial relationships within a candidate phylum. Interestingly,
there

is

no

apparent

correlation

in

phylogenetic

distance

between

the

TM7/Saccharibacteria species and their Actinobacteria hosts, which would indicate cospeciation (Figure 4.3a). This suggests that the parasite-host interaction evolved
separately, likely after oral colonization, and were not necessarily linked to speciation
events. Host specificity appears stringent for TM7x, as closely related Actinomyces
cannot substitute the strain that it was co-isolated with (45). We have further expanded
on our understanding of TM7 physiology by identifying cells from distinct TM7 lineages
that can simultaneously “infect” the same host cell and that the same TM7 species can
“infect” distinct hosts in vivo. That indicates some flexibility in the establishment of the
ectosymbiosis. The molecular mechanisms of interaction and the host specificity
determinants for the different TM7 species and their hosts remains unknown. As other
members of the “Candidate Phyla Radiation” are hypothesized to have an obligate
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parasitic/symbiotic lifestyle (215), isolation of additional TM7 and related symbiotic
systems will be important for better understanding of the evolution of these microbial
lineages and characterizing the molecular strategies that ectobionts use to attach to host
cells and obtain metabolic building blocks.
All TM7 are very small epibiont cocci (<0.5 m in diameter) on the surface of host
cells, observed using both fluorescence in situ hybridization (FISH) and staining with the
TM7 antibody (Figure 4.3b). TM7 HOT351 cells appear primarily associated with the pole
of the bacillus-shaped Actinomyces host cells, while for the others, there does not appear
to be a localization preference (46). As with TM7x-A. odontolyticus XH001, we found that
growth conditions affect the relative abundance of the different TM7 in the co-cultures,
although each appears to have its own characteristics. Whereas TM7x abundance
increased in the presence of oxygen, TM7 HOT351 and 346 were inhibited by micro-oxic
environment as their hosts were also inhibited. The physiology of each TM7 lineage is
therefore linked to that of their hosts and the subject of ongoing studies for all of the
symbiotic systems we isolated.
Antibody-enabled single cell genomics. Because not every organism may be
readily culturable, we also tested the targeted isolation approach to obtain single cell
genomic information for the various oral TM7/Saccharibacteria lineages. Targeted
collection of specific genomes could further provide hypotheses to begin to isolate other
uncultured lineages of bacteria. Flow cytometry enables analysis of over 5,000 cells per
second, therefore taxa present at extremely low abundance could be targeted for single
cell isolation and genomic sequencing. Labeled samples from healthy individuals and
from individuals with periodontitis were therefore used for single cell sorting and MDA.
We identified over two dozen TM7 single-cell amplified genomes (SAGs), which were
assigned to six human oral taxa, HOT’s 346, 348, 349, 351, 352 and 353/952. SAGs from
two other TM7 HOTs (350 and 356), identified through un-targeted single-cell isolation
(32, 34), were also included in the analysis. Unlike genomes derived from metagenomes
(MAGs), that most often lack rRNA sequences and are difficult to match with lineages
previously known based on 16S studies, SAGs enable such comparisons. This is
important for organisms that span a wide taxonomic space (such as the oral
Saccharibacteria), ranging from species/subspecies to genera and families/orders. In
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total, we sequenced and assembled 23 of the SAGs, representing four of the six groups
of TM7/Saccharibacteria in the human oral microbiome (Groups 1, 2, 3 and 5) (Table
S4.1). The assembled SAGs ranged from 0.25 to 1 Mbp (median 0.62 Mbp), reflecting
different levels of genome completion (Figure 4.4a, Figure A4.4, and Table S4.1). In
comparison, the closed genome of TM7x is 0.7 Mbp (45), while MAGs of
TM7/Saccharibacteria from open environments range between 0.8-1.2 Mbp (44, 47, 193).
Based on conserved single copy core genes (Table S4.1), we estimated the level of
completion of the SAGs to be between 40 and more than 90%. The oral TM7 genomes
share a core of 279 shared orthologous gene families, mostly related to genetic
information processing, transport and secretion functions. The small genome size,
especially for oral TM7, is a result of gene (and metabolic capability) loss associated with
their parasitic lifestyle, which likely extends across all oral phylotypes. However, it is not
known if TM7 from open environments are dependent on physical association with other
bacteria. It has been proposed, based on the interspersed oral and environmental TM7
lineages, that multiple independent acquisitions of oral microbiota were followed by
independent genome reductions (and possible bacterial host associations) among the
TM7 subtypes (216). As humans share close relatives of oral TM7 with other mammals
(Figure 4.3a and Figure A4.5), oral colonization by these bacteria likely occurred early
in the evolution of mammals, if not before. A two-fold increase in the abundance of genes
related to defense mechanisms (CRISPR-Cas, restriction-modification systems and
putative virulence factors) and a reduction in genes associated with cellular motility and
redox processes (Figure A4.6 and Table S4.1) are also potentially linked to adaptation
to a epibiotic lifestyle (45, 208, 216).
As with other related lineages from the “Candidate Phyla Radiation” (CPR)(27,
215), genome reduction in TM7/Saccharibacteria has led to the loss of numerous
functions, including biosynthesis of essential amino acids and vitamins. All TM7 appear
to have an obligately fermentative metabolism with no respiratory functions, as electron
transport chains are lacking. None of the TM7 can synthesize sugars by gluconeogenesis,
as the key enzyme fructose-1,6-bisphosphatase is absent. Glucose and other
monosaccharides may be fermented via the pentose phosphate and heterolactic
fermentation pathways. We identified, however significant differences between the
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Figure 4.4. Comparison of oral TM7 at genomic and metabolic levels. a. Alignment of
oral TM7 genomes using Anvi’o (217, 218), showing basic genome characteristics,
distribution of core genes and functional gene categories across the various phylotypes.
b. Reconstruction of central metabolic pathways for TM7 bacteria, based on completed
genomes and draft SAG/MAG assemblies. Blue or green circles indicate broad presence
in environmental and animal-associated TM7. Semicircles indicate occasional presence,
associated with specific environments. Absent reactions are in red. The absence of genes
encoding the three essential pentose phosphate pathway enzymes in human oral TM7 is
highlighted in gray.
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various types of TM7 based on environmental origin and phylogenetic grouping (Figure
4.4b). TM7 genomes from open environments encode a nearly complete pentose
phosphate pathway coupled with heterolactic fermentation, which could generate
reduced NADPH and ATP via substrate-level phosphorylation by acetate kinase and
pyruvate kinase. However, genes encoding two of the enzymes for the terminal part of
the glycolytic cycle, phosphoglycerate mutase and enolase could not be identified in any
of the environmental TM7 genomes, although they are present in all oral TM7. On the
other hand, all human TM7 appear to lack important enzymes for the initial NADPHgenerating reactions of the pentose phosphate pathway and also a key enzyme for
heterolactic fermentation, xylulose phosphate phosphoketolase. Therefore, oral TM7 may
use hexose-pentose interconversions and primarily operate glycolysis reactions for ATP
synthesis. Evidence of several other differential gene (and metabolic potential) loss
between

various

lineages

of

TM7

(acetate

kinase,

lactate

dehydrogenase

phosphofructokinase and phosphoenol pyruvate synthase), suggests that central
metabolic pathways have been in continuous reshaping and reflect adaptation to specific
open environments and oral niches (Figure 4.4b).
Because TM7 bacteria are auxotrophs for amino acids, nucleotides and vitamins,
they require efficient uptake mechanisms. Based on comparative genomic analysis of
host-associated and open environment TM7 genomes we identified only a handful of
recognizable transporters. Paucity of canonical transport mechanisms has been noted in
other obligate symbionts (e.g. Nanoarchaeota, insect intracellular endosymbiotic
bacteria), where it has been proposed that direct cytoplasmic bridges (219) or specialized
proteins that change membrane permeability (220) may enable intercellular molecular
fluxes. In TM7, as in Nanoarchaeota, such transport processes must occur over an area
only few nanometers across (164). As such ectobionts may be able to detach from their
host cells and survive free for a limited time, they may have mechanisms to maintain
some energetic independence (ATP and reducing equivalents) by acquiring specific
central metabolic substrates directly from the environment. We hypothesized, based on
the glycolytic pathway predicted in all human oral TM7 (Figure 4.4b), that
supplementation of the culture medium with glycolysis substrates might stimulate growth
if they could be utilized directly. As such, we tested media supplemented with 2-5mM
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additions of glucose, ribose, phosphoenolpyruvate, pyruvate or lactate, singly or in
combination. However, we did not detect any effect relative to any of the TM7 strains.
While we cannot conclude TM7 detached from their host cells could not uptake glycolytic
substrates in vivo, in laboratory cultures they appear to exclusively rely on metabolites
provided through cell contact with Actinobacteria. In several of the oral TM7 genomes we
identified the gene encoding a sugar efflux transporter for intercellular exchange
(PF03083), which, together with proteins containing cell wall binding repeat domains
(PF01473) might be involved in that process. Ultrastructural studies ultimately will be
required to better understand how the oral TM7 ectobionts interact with their hosts.
Reverse genomics for other “unculturable” microbial lineages. While the
success of using two effective antibodies against TM7/Saccharibacteria is unlikely a result
of any special features of its proteome, we further sought to test and expand this approach
to a microbial lineage that currently has no cultured representatives. We selected
candidate bacterial phylum SR1/”Absconditabacteria”, organisms present at low
abundance in a variety of environments including in the human oral cavity. SR1 bacteria
have highly reduced genomes, indicating likely dependence on interacting organism(s),
and have recoded the opal stop codon (UGA) for encoding glycine (32). Based on single
cell genomic data of human oral SR1 HOT345, we applied the same search criteria for
conserved membrane proteins with extracellular domains. We selected a predicted
surface exposed transglycosylase, also annotated as surface antigen involved in cell wall
biogenesis (Genbank accession RAL55607). The protein has one predicted
transmembrane helix and a ~300 amino acids globular extracellular domain. For this
protein target we selected that entire exposed domain for which gene synthesis, protein
expression and purification followed by antibody production were performed
commercially. The resulting antibody has been effective in capturing live SR1 cells from
human oral samples. Culture enrichments as well as analyses on the binding specificity
of that antibody on samples from various environments are under current investigation.

Discussion
Genome sequences have greatly expanded our understanding of microbial
diversity and evolution. However, the absence of cultured representatives of many
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lineages still hinders our ability to study the roles numerous lineages of Bacteria and
Archaea play in their environments and how they interact with others. Here we have
leveraged single cell genomic data to selectively isolate, using engineered antibodies,
cells of diverse species of TM7/Saccharibacteria for sequencing and cultivation along with
their interacting Actinobacteria hosts. As many bacterial and archaeal lineages have no
cultured representatives and are inferred based on their genomic sequence to depend on
other members of their communities, cultivation and partnership characterization are
essential. The causes of microbial “uncultivability” are numerous, and includes
requirements for specific nutrients and growth factors produced by other species, strict
interspecies interactions, slow growth, competition/inhibition, and dormancy (221, 222).
Traditional microbial cultivation approaches are stochastic or rely on selection for specific
physiological traits. Genomic inferences have occasionally been instrumental in
enrichment and isolation of several organisms but depend on identifying such traits, which
rarely allow for selection in complex enrichments and therefore are not universally
applicable. Physical retrieval of single live cells of target microbial taxa from complex
communities enables a high throughput search for optimal cultivation parameters and,
conceptually, could be applicable to any organism for which a suitable surface target can
be identified. While not every organism may be immediately culturable, single cell
genomics data from such target cells would further enable population studies, specific
physiological inferences and may ultimately lead to successful cultivation. Applying and
further developing this strategy to other yet-uncultured taxa could begin to fill the many
cultivation gaps in the tree of life.

Methods
Ethics Statement. Human subjects recruitment and sampling protocols were
approved by the Ohio State University Institutional Review Board and by the Oak Ridge
Site-Wide Institutional Review Board. Written informed consent was obtained from all
participants. The use of commercial custom antibodies was approved by the Oak Ridge
National Laboratory Animal Care and Use Committee.
Sample Collection and Processing. Saliva samples were self-collected by
healthy donors by passive drool, using a SalivaBio collection aid (Salimetrics LLC,
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Carlsbad, CA, USA), in sterile cryovials. 1-2 mL saliva were collected at least 2 hours
after eating or drinking, kept at room temperature and processed immediately or within 2
hours from collection. Recurring samples were collected from the same donors as needed
for individual experiments. Gingival crevicular fluid from patients with periodontitis was
collected from affected teeth using sterile endodontic paper points that were placed
immediately in sterile vials with 1 mL reduced dental transport media (Anaerobe Systems,
Morgan Hill, CA, USA), transported to the lab and further processed within 24 hours.
Patients with periodontitis were sampled once.
Oral microbiota samples were diluted 1:5 in dental transport media (L-1 distilled
water): Na thioglycollate 1.0 g, Na2HPO4 1.15 g, NaCl 3.0 g, KCl 0.2 g, KH 2PO4 0.2g,
MgSO4 x 7H2O 0.1 g, L-cysteine HCl 0.5g, pH 7.3), mixed by vortexing for 1 minute then
centrifuged at 1000 x g for 2 minutes to remove large particles. The supernatant was
passed through 10-m CellTrics filters (Sysmex, USA) and the cells were collected by
centrifugation (12,000 x g for 15 minutes), followed by resuspension in 1 ml PBS. An
aliquot was used for total bacterial DNA extraction using proteinase K digestion and
phenol-chloroform extraction (164). For fixation, an aliquot was fixed by addition of an
equal volume of ice cold, 100% ethanol and stored at -20oC overnight. For live cell sorting,
the processed microbiota samples were used immediately.
TM7a genome mining, epitope selection and antibody generation. For
selection of candidate proteins to serve as immunogens, we used the single cell genomic
data generated by Marcy et al. (28), the only oral TM7 genomes available at the time we
initiated this work. We used the TM7a (6806 protein genes) and TM7c datasets (590
protein genes), based on the annotations available in IMG (https://img.jgi.doe.gov)(223),
with the expectation that some of the genes may represent organisms other than TM7
(44). We first selected genes encoding proteins associated with membrane processes,
based on COG categories (transport functions, cell wall/membrane/envelope biogenesis,
extracellular structures), using the IMG assignments. The corresponding proteins were
analyzed for the presence of transmembrane anchoring helical domains using TMHMM
v.2.0 (224). From the list of proteins with such domains, we eliminated the ones annotated
as hypothetical as well as those shorter than 100 amino acids, as we aimed for final
selection of relatively large proteins with known function. The proteins that passed those
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criteria (117 combined between TM7a and TM7c) were analyzed by blastp against the
proteomes of all oral bacteria downloaded from the Human Oral Microbiome Database
(http://www.homd.org/). Forty eight of the proteins had high sequence similarity (>90%)
to proteins from species of Leptotrichia (Fusobacteria), indicating they are likely
contaminants, as previously reported (44). We then individually analyzed the remaining
sequences for number of transmembrane domains, number and size of predicted
extracellular domains, availability of three-dimensional structures for homologues from
other bacteria, and experimental data related to abundance or prior use as immunogens.
The top pick was penicillin-binding protein 2 (PBP2), which belongs to a class of proteins
with important roles in bacterial peptidoglycan synthesis (225). Both high resolution
crystal structure data (210) and multiple reports that anti-PBP2 antibodies can bind to the
cell surface of pathogenic bacteria (226, 227) were available. The closest homologues to
the TM7a PBP2 present in genomes of human oral bacteria had 30-40% pairwise
sequence

identity

(species

of

Selenomonas,

Leptotrichia,

Fusobacterium,

Streptococcus). To test the applicability of the approach with a protein for which 3D
structure or antigenic data were not available, we also selected CpsC as a target, as
cellular studies indicated a cell surface-exposed domain (228, 229). CpsC belongs to the
polysaccharide co-polymerases (PCPs) superfamily and is involved in capsular
polysaccharide biosynthesis (230). We found no homologues in the oral bacterial
genomes with a pairwise identity to TM7a CpsC over 30%.
For selecting peptides to serve as antigens, we analyzed the two protein
sequences for antigenic regions and peptide hydrophilicity using the online servers
ABCpred

(231),

BepiPred

(http://tools.immuneepitope.org/bcell)

(232),
and

IEBD

Bio-Synthesis

Analysis
peptide

Resource
design

tools

(https://www.biosyn.com), using a 16-18 amino acid-peptide threshold. We used BioSynthesis (Lewisville, TX, USA) for peptide synthesis and antibody production. For PBP2,
we identified 7 peptides that could serve as antigens and for CpsC we identified four
peptides (Figure A4.1). We next analyzed the location of the 7 peptides from TM7a on
the 3D structure of the protein based on the homologous regions of the E. coli PBPB
structure (PDB 3vma) using PyMOL (https://pymol.org/2/). Further details on structural
modeling and visualization are presented in the comparative structural analysis section.
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The selected antigen peptide (SGNIKYAKQRQKTVLTRMV) was one of the three
peptides with the most exposed residues. In the case of CpsC, because no experimental
3D structure was available, we selected an antigenic peptide (ESAIQEFKEQSKSLYGNS)
that is in a helical region of the predicted extracellular domain (Figure A4.1).
The two selected peptides were commercially synthesized by Bio-Synthesis
(Lewisville, TX, USA), with cysteine added at N (CpsC) or C terminus (PBP2), purified
and injected in rabbits. For antisera production, Bio-Synthesis used a 70-day protocol,
with 5 booster doses and 4 test bleeds followed by ELISA. We received serum batches
confirmed by ELISA to be reactive against the antigenic peptides. For IgG purification we
used HiTrap Protein A HP antibody purification columns (GE Bio-Sciences (Pittsburgh,
PA, USA) according to manufacturer’s protocol. For fluorescent IgG labelling of 100 g
IgG aliquots we used the Alexa Fluor™ 488 Antibody Labeling Kit from ThermoFisher
(A20181) according to manufacturer’s instructions.
Immunofluorescent labeling of oral microbiota samples and flow cytometry.
Aliquots of oral microbiota samples, processed as described above and suspended in
PBS were blocked for 30 minutes with 5% goat serum and a mixture of IgGs (1 g/mL
each rabbit anti-Ignicoccus IgG (233), anti-Clostridium IgG (234) and human IgG, I4506,
Sigma, St. Louis MO, USA) for blocking potential non-specific antibody-binding sites on
some oral bacteria. We also used 5% rabbit pre-bleed serum instead of the goat serum,
with no observed differences. Following blocking, fluorescently labelled anti-PBP2 or antiCpsC IgG were added to the samples at 0.1-1 g/mL. It was important to centrifuge the
antibody solution (15,000 x g for 5 minutes) and carefully recover supernatant, prior to
addition to the microbiota samples in order to reduce the background of fluorescent
particles. Antibody labelling was conducted for 1 hour at room temperature, followed by
either centrifugation (12,000 x g for 15 minutes) and resuspension in 2 mL PBS
supplemented with 1% serum or directly diluting in 2 ml PBS with 1% serum (mainly for
live cell sorting for cultivation experiments). After 30 minutes, the samples were analyzed
by flow cytometry. Negative controls included unstained oral sample (to check for autofluorescence), and samples processed in parallel with the oral sample but without
microbiota (to check for fluorescent antibody precipitates).
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For flow cytometry and cell sorting, we used a Cytopeia/BD Influx Model 208S
(Cytopeia, Seattle, now BD, San Jose, CA), in a biological safety cabinet (BSC) designed
specifically for the Influx cell sorter (Baker Co). Preparation of the flow cytometer for single
cell sorting for genomic amplification and sequencing was as we and other have
previously described (33, 235, 236). For sorting, we used a 70-m nozzle and the 488nm laser for forward-side scatter (FSC-SSC) analyses as well as fluorescence detection
and cell sorting trigger. Gating parameters were selected based on FSC-SSC and
fluoresce levels for each experiment and sample. A very low level of highly
autofluorescent particles (<0.01%, RFU>10 3) were observed in all samples in the
absence of staining with the antibody and gating parameters were set to avoid sorting
such particles. For genomic and community diversity analyses single or pools of
fluorescent particles were deposited in 3 μL of DNA-free, Tris–HCl (10mM pH 8.0), 1mM
EDTA (TE) in individual wells of 96 well plates. We observed sufficient fluorescence signal
with primary labelled antibody preparations. However, if the signal would be low, using a
secondary labelled antibody (e.g. goat anti-rabbit IgG) would provide signal amplification.
Isolation and cultivation of oral TM7 bacteria. For cultivation, we used saliva
samples collected recurrently from three healthy donors and processed them as detailed
above. Antibody staining was performed as already described. For the initial cultivation
tests, in 200 L liquid media in 96-well plates, we used as basal media commercial or
home-made brain heart infusion (BHI, Difco), Oral Treponeme Enrichment Broth (OTEB,
Anaerobe Systems, Morgan Hill, CA, USA), MTGE Broth (Anaerobe Systems), Tryptic
Soy broth (TSB, Difco) supplemented with various additional factors (ATCC vitamins,
trace minerals, clarified filtered saliva, pig gastric mucin, sugars, amino acids and
nucleobases, N-acetyl muramic acid, N-acetyl glucosamine, pyruvate). Following flow
sorting, performed as already described, the plates were incubated in an anaerobic
chamber (COY, Grass Lake, MI, USA) at 37 oC, under 85%N2, 10%CO2, 5%H2 or in
anaerobic jars to which we added air via a syringe port to reach 2% O 2. To test for TM7
growth, after 48-72 hours we retrieved 100 l culture using multichannel pipettes and
vacuum-filtered through 0.2 m filter 96-well plates (Millipore, Burlington MA, USA). The
cells were washed with 200 L PBS. Then, 20 L TE were added to the filter. The plate
was placed on an orbital shaker at 100 rpm for 5 minutes at room temperature. 10 L of
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the cell suspension was then recovered in 96 well PCR plates, to which we added 10L
lysis solution (0.13 M KOH, 3.3 mM EDTA pH 8.0). The plate was covered with adhesive
foil and heated in a PCR machine at 95C for 5 min. The plate was immediately cooled
on ice after which, 10 L neutralization buffer (0.13M HCl, 0.42M Tris pH 7.0, 0.18M Tris
8.0) was added. We then used 1.5-2 L of the lysate in PCR reactions with universal and
TM7 primers, as detailed earlier. The presence of TM7 in PCR positive cultures were
further confirmed by Sanger sequencing and the cultures were transferred into fresh
medium under the original growth conditions. We initially obtained TM7 positive cultures
using BHI, OTEB, MTGE and TSB, primarily under microaerobic conditions. In liquid
microcultures, in addition to TM7 HOT352 (Group 1), we also identified TM7 HOT347
(Group 1) and HOT870 (Group 6). However, none of positive microcultures were pure
and contained various other bacteria (Streptococcus, Fusobacterium, Campylobacter,
Actinomyces, Propionibacterium and Veillonella). While TM7 survived in those liquid
cultures for several passages, we have not identified the hosts for HOT347 and HOT870.
Because liquid cultures in 96 well plates were difficult to monitor and to prevent
overgrowth, we used cell deposition and cultivation on solid media for final isolation
experiments.
For cultivation on solid medium we used DMM-agar (237) supplemented with 2%
glucose, 0.1g/L casamino acids and 10% sheep blood as well as BHI-agar supplemented
with 10% sheep blood. Single cells were deposited by flow sorting in a 10x10 array on
each plate, followed by incubation at 37 oC under anaerobic or microaerobic conditions.
Visible colonies formed after 3-5 days of incubation (Figure A4.3) were sampled with
sterile tips and analyzed by direct PCR using primers 27FM-510R (TM7 specific) and
27FM-1492R (universal bacteria). Secondary screening for TM7 bacteria was also
performed using primers 910F (5’CATAAAGGAATTGACGGGGAC 3’) and 1177R (5’GACATCATCCCCTCCTTCC-3’) under the conditions 95°C for 2 minutes, 32-34 cycles
of 95°C for 30 seconds, 61°C for 30 seconds, 72°C for 1 minute, followed by 72°C for 5
minutes. Single band products were directly sequenced at Eurofins Genomics (Louisville,
KY, USA) using Sanger chemistry. For colonies that contained other bacteria
(Streptococcus, Veilonella), the original TM7-positive colony was repeatedly streaked on
fresh plates until colonies containing only TM7 and a host actinobacterium were obtained.
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For TM7 HOT346, a pure co-culture with Cellulosimicrobium cellulans was obtained
following a second round of antibody staining and sorting (Figure A4.3). TM7
enrichments and co-cultures with hosts could be maintained as freezer stocks in media
containing 10% DMSO at -80°C. For further physiological characterization of TM7
metabolism potential we supplemented solid (with 10% blood) and liquid (without blood)
BHI media with 2-5mM of ribose, lactate, pyruvate, or phosphoenolpyruvate at 37°C or
39°C in duplicate and screened for TM7 relative abundance after 2 and 5 days of
incubation and a subsequent passage in the same media, as described above. Compared
to a BHI only control, no significant differences were observed.
For microscopic characterization of co-cultures, cells were fixed in 50% ethanolPBS overnight at -20°C. For fluorescence in situ hybridization we used cell immobilization
and dehydration on gelatin-coated slides as described (238), with 30% formamide in the
hybridization

buffer.

The

probes

we

used

were

EUB338

(5’GCTGCCTCCCGTAGGAGT3’) (universal bacteria), labeled with Alexa536 or
Alexa647 and TM7-567 (5’CCTACGCAACTCTTTACGCC3’) labeled with Alexa488. In
some experiments we also labelled cells with CellBrite Fix 640 Membrane Stain (Biotium)
prior to fixation. Following hybridization and washing, the slides were covered with
EverBrite Mounting Medium (Biotium) and analyzed by epifluorescence microscopy using
a Zeiss AxioImager microscope. Color photographs were taken using a Canon 7D digital
SLR and were merged in Adobe Photoshop. For immunofluorescence microscopy, in
addition to the anti-PBP2-CspC antibody mix (labelled with Alexa 488), we also used a
broad anti-Actinomyces rat IgG, generated by immunizing rats with a mix of Actinomyces
species (A. odontoliticus, A. israelii, A. naeslundii, A. gerencseriae) and labeled with
Alexa 647. The slides were first blocked with the same cocktail used in antibody staining
for flow cytometry and stained with a mix of anti-PBP2-CspC and anti-Actinomyces
antibodies for 60 minutes. After washing with PBS five times, the slides were mounted
and visualized as above.
Genomic amplification, taxonomic analysis and single cell genome
sequencing. Sorted single cells or cell pools were stored frozen at -80oC until genomic
DNA amplification. For amplification by MDA we used a protocol that we and others have
described in detail previously (33, 235, 236). Single cells amplified genomes (SAGs) were

91

screened

for

the

presence

of

TM7

by

PCR

using

the

primers

27FM

(5’AGAGTTTGATYMTGGCTCAG-3’) and 510R (5’-CTCTTTACGCCCAGTCAC-3’) by
denaturation at 94°C for 3 minutes followed by 32 cycles of amplification (95°C for 30
seconds, 62°C for 30 seconds, 72°C for 30 seconds) and a final extension at 72°C for 5
minutes. PCR products were sequenced on an ABI3730 DNA Analyzer (Applied
Biosystems), at the University of Tennessee Sequencing Facility or at Eurofins Genomics
(Louisville, KY, USA), using the same primers. Resulting chromatograms were manually
edited for low quality regions using Geneious (https://www.geneious.com/) and
sequences were used for phylogenetic identifications using the HOMD SSU rRNA
database (http://www.homd.org/). Samples for which the chromatograms were not
homogeneous and that denoted potential heterogeneous template DNA (more than one
sorted cell) were not further used. While a mixed chromatogram may indicate the
presence of a symbiont of TM7, because they could not be unambiguously distinguished
from either DNA contamination or non-specifically adherent cells co-sorted with TM7, so
we did not pursue characterization of mixed SAGs.
To characterize the microbial diversity in cell populations sorted following antibody
staining (10-100 cells), genomic amplification by MDA was conducted the same way as
for single cells. The amplification product was first purified using a Zymo genomic DNA
cleanup kit (Zymo Research, Irvine CA, USA). To determine the microbial composition of
the original oral microbiota samples we used gDNA purified from the saliva and the
subgingival samples. Microbial diversity was determined by amplification of the
hypervariable V4 region of SSU rRNA gene followed by MiSeq amplicon sequencing. We
followed the protocol described by Lundberg et al. (239), with a modification in the
universal primers. Specifically, because the canonical 515F primer sequence
(5’GTGCCAGCMGCCGCGGTAA) does not recognize TM7 rRNA, we supplemented the
PCR reaction mix with 5% of a 515F-derivative that can bind TM7 rRNA
(5’GTGCCAGCMGCCGCGGTCA).

The

reverse

primer,

806R

(5’GGACTACHVGGGTWTCTAAT) can recognize the full diversity of oral bacterial SSU
rRNA. The purified amplicons were sequenced on the MiSeq platform (Illumina, San
Diego CA, USA) on v2 or v3 sequencing chips using 2x250 nt reads. Read processing
and microbial diversity analysis was performed using the software programs cutadapt
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(240), usearch (241) and QIIME (242) as well as the HOMD SSU rRNA taxonomy
database and following the commands and parameters listed in the “MySeq sequence
analysis” supplementary file. To determine if the 254 nt V4 amplicon provides sufficient
resolution to enable distinguishing the different human oral TM7 phylotypes, we
determined the pairwise sequence identity between the 13 main types of oral TM7 OTUs
and performed phylogenetic analysis including the TM7 OTUs identified based on
sequencing the V4 amplicon (TM7HOTs_OTUs V4.fasta supplementary file). As shown
in Figure A4.2, with the exception of 2 OTU pairs (HOT346-HOT869 and HOT352HOT952), all other TM7 could be readily distinguished in MiSeq amplicons, with pairwise
identity values bellow 98% and sufficient phylogenetic resolution.
Purified DNAs of TM7 SAGs selected for genomic sequencing were used to
generate libraries and were sequenced on Illumina HiSeq (100 nt paired reads) at the
Hudson Alpha Institute for Biotechnology (Huntsville, AL, USA) or on MiSeq (250 nt paired
reads) at ORNL. Approximately 100 million reads were obtained for each SAG sequenced
on HiSeq and 10 million for the MiSeq SAGs.
SAG assembly, annotation and comparative genomic analysis. For individual
assembly, the reads for each SAG were trimmed using Trim Galore 0.4
(https://github.com/FelixKrueger/TrimGalore)

and

assembled

using

SPADES

(v3.9.0)(243). Removal of non-TM7 contigs (human and other bacterial sequences) was
performed by a combination of GC-content-based binning, and Emergent Self-Organizing
Maps (ESOM) based on kmer frequency (244). Further contamination was removed using
DNA and protein BLAST and single-copy gene analysis (245, 246). Lastly, further
assembly in Geneious (v8-10)(179) consolidated some contigs and the final cleaned
genomes were analyzed with Prokka (v1.11)(247) for gene prediction and annotation.
Completion and contamination estimates were calculated using CheckM (v1.0.11)(246)
using the lineage workflow and a manually adapted gene-list workflow containing 42
single copy genes conserved in CPR Bacteria (248) (Table S4.1, Figure A4.4). Pfam
(v31)(249), eggNOG (v4.5.1)(128) and Interproscan (v5.27-66.0)(250) databases were
used for protein assignment to families and orthologous groups. Anvi’o (v5.1) was used
for core genome analysis and identification of conserved COGs following the
pangenomics pipeline with mapping of eggNOGs (217, 218) (Table S4.1 and Figure 4.4).
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NCBI, IMG and Geneious were used for basic homology searches and for obtaining
genomic data for further metabolic inference analyses. SSU rRNA and concatenated
single-copy protein gene trees were generated in Geneious using RAxML, with estimation
of all free parameters and 100 bootstraps (Figure A4.5). The TM7 SAGs sequences and
associated metadata were deposited in Genbank under Bioproject PRJNA472398. SSU
rRNA sequence alignments that include reference strains as well as detected phylotypes,
SAGs and isolates obtained in this study are provided as supplemental files
“TM7_16S.fasta” and “Actinomyces_16S.fasta”.
Protein structure modeling. The glycosyltransferase domain of PBP2 from TM7a
(residues 95-278) and TM7x (residues 145-334) was modeled using a combination of
homology modeling and coevolution-based residue-residue contact prediction. We used
the GREMLIN web server (251-253) to identify structural templates, predict residue
contacts based on coevolution analysis, and generate contact restraints for Rosetta
structural modeling (211). Briefly, the server uses HHblits (254) and to generate a multiple
sequence alignment (MSA), which is then filtered to include only sequences that cover at
least 75% of the query sequence, have fewer than 75% gaps, and have a maximum
mutual sequence identity of 90%. From this MSA, GREMLIN learns a global statistical
model that accounts for both sequence conservation and coevolution. Next, HHsearch
(255) was used to identify potential templates for homology modeling from the Protein
Data Bank (PDB)(256). More than 9,300 sequences of PBP2 homologs were identified
from the sequence database search. For the ~190 residue proteins this number
corresponds to a sequence/length ratio of ~51, indicating the robustness of the predicted
residue contacts.
For both TM7a and TM7x, the following five templates identified by HHsearch were
used as templates for modeling PBP2: 3VMA (257), which is missing part of jaw
subdomain, 3UDF (258) (also missing the jaw subdomain), 2OQO (259), 2OLV (210),
and 3VMT(260) (Figure A4.7). Although multiple template structures are available, we
included coevolution information to provide additional benefits compared to standard
homology modeling. We used map_align (https://github.com/gjoni/map_align) to align the
contact maps predicted from the coevolution analysis to selected templates identified by
HHsearch. The initial threaded models generated by map_align were then used as input

94

for Rosetta hybrid modeling, and all models were given weights of 1.0. Fragment files
were obtained with the Robetta server (261). We generated 10,000 models with both
sigmoidal and bounded restraints during coarse-grained sampling and only sigmoidal
restraints during full-atom refinement (253). Models were ranked on the basis of the sum
of their Rosetta energy and the restraint score. The final models are shown in Figure
A4.7. PyMOL (https://pymol.org/2/) and pdb format files of the models are also provided
as supplementary data (PBP_structural_alignment.pse, tm7a_S_0876_ma1.1.pdb and
tm7x_S_0959_ma1.5.pdb).
CpsC (residues 1-197) was modeled with Rosetta using coevolution-derived
residue-residue contact restraints. More than 3,700 sequences obtained with the
GREMLIN webserver were used to perform the coevolution analysis. A PyMOL file of the
3D model structure is provided as supplementary data (cpsc_epitope.pse).
We analyzed the SAGs for the presence of the genes encoding the two proteins
used as epitopes for raising antibodies. For PBP2, we found the gene in SAGs
representing all of the TM7 lineages isolated by antibody capture. For Cbp2, we found
the gene in only three of the lineages. This gene is also missing in the complete genome
of TM7x, so the Cbp2 protein is not present across all TM7. The level of sequence
similarity at the epitopes level varied between the different TM7 as compared to the
original TM7a sequence but there were multiple conserved amino acids across all
lineages. To better understand the structural basis of epitope recognition in the different
TM7 PBP2, we modeled the three-dimensional structure of the TM7a/HOT348 and
TM7x/HOT952 proteins based on crystal structures available for several homologues
(Figure A4.7). In addition to structural templates, we included coevolutionary information
in the form of residue-residue contacts (252) predicted from a deep multiple sequence
alignment to improve the structural models. Because we were primarily interested in
identifying structural determinants of epitope recognition, we generated structural models
only of the extracellular, N-terminal glycosyltransferase domain (residues 95-278 in the
TM7a PBP2 sequence). The final models share a similar overall fold and structure
between TM7a and TM7x PBP2 even though they are only 37% identical. The -helix
containing most of the epitope is located on the surface of the protein, with some of the
conserved residues buried and others exposed or partially exposed (Figure 4.1b). A
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similar epitope topology was observed in the Cbp2 protein model (Figure 4.1c). The
exposed residues include multiple polar and charged amino acids, which may be
responsible for antibody recognition and binding. It is important to note that although the
sequence similarity in the epitope region is as low as 35-50 % across the TM7 lineages,
IgG variants were able to bind their target on the cell surface. Although the specificity
breadth cannot be predicted, especially when only a single target sequence is available
(as was the case with TM7a), polyclonal antibodies can therefore recognize multiple
related species and increase the diversity in targeted isolation of microbial cells. Broader
specificity can also result in cross reactivity with more distant, non-target organisms,
potentially explaining some of the additional taxa we observed in pooled cell populations.
Data Availability. Curated TM7 SAG sequences were deposited in GenBank
under the Bioproject PRJNA472398. Aligned SSU rRNA sequences are provided as
supplementary files. Raw sequence datafiles are available from the authors upon request.
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Figure A4.1. Antigenic peptide selection. a. Alignment of TM7a PBP2 with the E. coli
homologue based on 3D structure (3vma). Alpha helices are in red, beta sheets are
shown as green arrows. The location of the predicted antigenic peptides (epitope 1-7) are
in gray, and the selected epitope for antibody production is in blue. Three-dimensional
structure (3vma) on the right shows the location of epitopes 2, 5 (selected), and 7 in gold
color. b. Predicted secondary structure and topology of TM7a CpsC. The four predicted
antigenic peptides (epitope 1-4) are indicated, the selected one is in blue.
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Figure A4.2. SSU rRNA V4 taxonomic resolution. a. Phylogenetic tree (Jukes Cantorcorrected distances) of human oral TM7 reference sequences (HOTs) and MiSeq OTUs.
Most OTUs can be unambiguously assigned to known HOT types. b. Pairwise identity
matrix for human oral TM7 HOTs (SSU rRNA V4 region).
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Figure A4.3. TM7-host colonies following single cell sorting and incubation at 37C. a.
Cells from primary TM7 HOT346-348 colony were re-stained with the antibody and b.
sorted based on the gate shown in the flowgram on BHI-blood agar plate. The circled
colonies contained a pure TM7 HOT346-Cellulosimicrobium co-culture. c. Primary colony
of pure TM7 HOT351-Actinomyces sp. HOT897 co-culture. d. Primary colony of TM7
HOT352/952-Actinomyces odontolyticus, also containing Streptococcus oris.
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Figure A4.4. Completion level and contamination analysis of oral TM7 SAGs. Analysis
was based on CheckM using 42 single copy genes conserved in bacteria from the
“Candidate Phyla Radiation”. Four closed TM7 genomes (TM7x, RAAC3, GWC2, and S.
aalborgensis) were also analyzed for comparison. Each row represents a genome with
colored bars representing the presence/absence/copies of single-copy genes. SAGs are
organized based on which phylogenetic group they belong to.
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Figure A4.5. Maximum likelihood phylogeny of concatenated proteins from TM7 bacteria
based on SAGs, MAGs, and TM7x. SAGs in red were sequenced as part of this study.
Other host-associated TM7 are indicated by gray dots. Black dots at nodes indicate
bootstrap support >80, white circles are support values of 50-80%. Scale bar is inferred
number of substitutions per site.
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Figure A4.6. Abundance of COG categories between environmental and human oral
TM7 bacteria.
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Figure A4.7. Structure modeling of TM7 PBP. a. Structural templates for the GT domain
of PBP2 from TM7a and TM7x identified by HHsearch. b. Target sequences for structural
modeling. Structural models of PBP2 were generated for the regions in black text. The
epitope region in TM7a is boxed. c. Final models of the glycosyltransferase domain of
PBP2 form TM7a (left) and TM7x (right). Residue contacts predicted from coevolution
analysis are shown as yellow lines. The models of the GT domain satisfy the coevolution
restrains well and show the overall folds of the two PBP variants are similar.
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CHAPTER FIVE – Summary, Conclusions, and Future Directions
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Periodontitis is the leading cause of tooth loss worldwide and is hypothesized to
contribute to systemic diseases such as cardiovascular disease and irritable bowel
disease (20, 74, 262). With over 770 species level bacterial taxa identified in the human
oral cavity, approximately 1/3rd represent uncultivated members (12, 13), their
recalcitrance may be due to dependencies on co-evolving bacterial community members
yet identified. Some of the periodontal pathobionts have been recognized but many
disease-associated lineages remain uncultured (17). Isolation and cultivation of these
disease-associated microorganisms is essential to fully understand their role in disease.
Isolation allows us to move away from just mere correlation with disease to direct
causation so that we can begin to piece together an appropriate model for how such
microbiome-associated diseases are acquired. Additionally, discovering new information
about these organisms would allow for the development of innovative treatments and
possible means of prevention for periodontitis. This dissertation takes a dual approach
towards elucidating novel disease-associated lineages of bacteria in the human oral
cavity using cultivation-dependent and -independent approaches (Figure 1.1).
Sulfate-reducing bacteria (SRB) have been detected in periodontal pockets (55)
and culture-independent studies have linked the SRB genus Desulfobulbus with
progressive periodontal disease in the oral cavity (58, 59). Single-cell genomic analysis
was able to probe the initial functions of the little known Desulfobulbus genus in the
human oral cavity (33), but without a cultured representative, truly understanding the role
of this organism in the microbial community remains difficult. Chapter 2 describes the
isolation and characterization of the first species of the Desulfobulbus genus from the
human oral cavity. With collaborators from the Ohio State College of Dentistry, we
received human periodontal samples and enriched for SRB and isolated Desulfobulbus
oralis sp. nov. In working towards the isolation of D. oralis, we obtained a stable co-culture
of D. oralis and Fusobacterium nucleatum, another native oral microbial species. Further
physiological characterization identified that D. oralis required by-products produced by
F. nucleatum for growth in pure culture to occur (186). D. oralis is the first humanassociated representative of its genus and has provided unique insights into the genomic
and physiological changes that have occurred as D. oralis co-evolved with its human host
and to the emergence of pathogenicity. In addition to limited metabolic versatility and
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niche specialization, we identified horizontal gene acquisitions from other oral microbiome
members, such as toxins like leukotoxin and hemolysins, that can potentially trigger a
proinflammatory response in oral epithelial cells. We showed that D. oralis is not merely
a passive by-stander in disease progression but may actively contribute to disease
etiology. This relationship could only be understood after isolation.
Furthermore, understanding the relationship between D. oralis and F. nucleatum
will provide useful insights to aid in the cultivation of more disease-associated bacterial
lineages. Other oral microorganisms are dependent on F. nucleatum for growth (39, 40)
but it remains unknown what molecules produced by F. nucleatum stimulate growth
Preliminary tests with defined additions of amino acids, vitamins, siderophores, and
complex nutrients did not alleviate the dependency of D. oralis for F. nucleatum filtrate.
Additionally, the growth promoting component(s) of the F. nucleatum filtrate could not be
inactivated with heating or protease treatment, suggesting it is not a protein but rather a
small molecule(s) of some kind. Chapter 3 begins to elucidate the growth promoting
characteristics of F. nucleatum using a metabolomics approach. Data analysis of mass
spectrometry identified the metabolic by-products of F. nucleatum growth and we
identified what F. nucleatum may be providing to stimulate D. oralis growth.
As emphasized with the isolation of D. oralis, cultivation is ideally the ultimate goal
to allow one to fully understand the repertoire of bacteria that make up the human
microbiome and their roles in health and disease. However, a recent view of the tree of
life has revealed an even more expansive assessment of bacterial lineages identifying
entire phyla of currently uncultured organisms (27). Some of these lineages exist within
the human oral microbiome (7). Specifically, one such phylum, the TM7 phylum
(Candidate Division Saccharibacteria), has been recalcitrant to cultivation for many years
with only one TM7 species, TM7x, isolated from the human oral cavity (45). Although the
isolation of TM7x has significantly influenced our view of the oral microbiome, it is only
one isolate of a large taxonomic diversity of TM7 bacteria in the oral cavity (29) and
provides limited insight into the physiological diversification and roles these bacteria play
there. Chapter 4 demonstrates a novel reverse-genomics approach using in-silico
antibody design based on published sequencing data to target a wide diversity of TM7
bacteria in the human oral cavity for genomics and cultivation. This method allows for
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cultivation of bacteria who must also be co-isolated with their respective obligate bacterial
hosts; a bottleneck that has resulted from classical cultivation techniques.
We validate this with the cultivation of a previously uncultured lineage of TM7
bacteria HOT351 and its formerly uncultured host, Actinomyces HOT897. In addition to
live cultivation, we also sequenced twenty-three human oral TM7 single-cell genomes
covering a large taxonomic diversity (eight unique OTUs) of the TM7 phylum in the oral
cavity, the largest collection so far at the individual OTU level. Comparative genomics of
this large dataset has provided a robust analysis of a core human oral TM7 genome and
comparisons with free-living TM7 genomes has identified what traits may be important for
human host-association. As compared to free-living TM7 relatives, human oral TM7
bacteria are enriched for protein families of known virulence factors and novel viral
defense mechanisms.
Next-generation sequencing has greatly informed our understanding of the vast
array of microorganisms on Earth however the limited number of cultured representatives
of entire phyla still hinders our ability to truly understand the roles these organisms really
play in their environments. Inferences can be made regarding their functions based on
genomics and phylogenetic placement but without being able to test those hypotheses in
the lab, sequencing remains merely hypothetical. The dual approach of my dissertation
in leveraging next-generation sequencing analysis to bring disease-associated bacterial
lineages into culture will uncover new information about not only individual
microorganisms but how these organisms contribute to microbial community architecture
and the specific interactions that may lead to dysbiosis and disease.
Moving forward, figuring out the “mystery factor” that F. nucleatum is producing to
stimulate growth of D. oralis is priority. To do so, one can utilize preparative HPLC to
further fractionate the EtAc2 sample and continue to narrow in on what is in this
supporting fraction. As it may be more than one compound working in synergy with
hydroxybutyric acid, then this less complex fraction may be better resolved by LC-MS and
NMR as GC-MS has limitations in the types of compounds that it can identify. Further,
heavy labeled substrates (13C) can be purchased or synthesized of the identifying
compounds and fed to D. oralis to determine whether or not these are actually being
utilized by D. oralis. If some growth stimulation is occurring, then it may be a concentration
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problem (either not enough or inhibitory concentrations of the target compound) that
needs to be further investigated. Lastly, it would be interesting to test whether the final
identified compound(s) can support growth of other oral bacteria that have been shown
to be dependent on F. nucleatum for growth.
Continued advancement and optimization of the “reverse genomics” is dually
important. Culturing additional representatives of TM7 will uncover more information
regarding host specificity and interactions. Likewise, expanding to environmental TM7
and other (currently uncultured) lineages of bacteria, such as SR1 and GN02, can identify
whether all CPR organisms have actinobacterial hosts in host-associated or free-living
environments or have evolved separately with different hosts. Understanding the range
of hosts can also aid in understanding limitations of host association (such as only Gram
positive organisms capable of being hosts or in identifying shared features not present in
non-host vs. host bacteria).
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